id
stringlengths 14
14
| page_content
stringlengths 10
2.06k
| source
stringclasses 1
value |
|---|---|---|
643a8c94f60d-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM) 875
V60.2 Insufficient social in surance or welfare support
V60.2 Lack of adequate food or safe drinking water
V60.2 Low income
V60.3 Problem related to living alone
V60.6 Problem related to living in a residential institution
V60.89 Discord with neighbor, lodger, or landlord
V60.9 Unspecified housin g or economic problem
V61.03 Disruption of family by separation or divorce
V61.10 Relationship distress with spouse or intimate partner
V61.11 Encounter for mental health services for victim of spouse or partner neglect
V61.11 Encounter for mental health servic es for victim of spouse or partner
psychological abuse
V61.11 Encounter for mental health services for victim of spouse or partner violence,
Physical
V61.11 Encounter for mental health services for victim of spouse or partner violence,
Sexual
V61.12 Encounter for mental health services for perpetrator of spouse or partner
neglect
V61.12 Encounter for mental health services for perpetrator of spouse or partner
psychological abuse
V61.12 Encounter for mental health services for perpetrator of spouse or partner
violence, Physical
V61.12 Encounter for mental health services for perpetrator of spouse or partner
violence, Sexual
V61.20 Parent-child relational problem
V61.21 Encounter for mental health servic es for victim of child abuse by parent
V61.21 Encounter for mental health services for victim of child neglect by parent
V61.21 Encounter for mental health services for victim of child psychological abuse by
parent
V61.21 Encounter for mental health services for victim of child sexual abuse by parent | dsm5.pdf |
643a8c94f60d-1 | parent
V61.21 Encounter for mental health services for victim of child sexual abuse by parent
V61.21 Encounter for mental health services for victim of nonparental child abuse
V61.21 Encounter for mental health services for victim of nonparental child neglect
V61.21 Encounter for mental health services for victim of nonparental child
psychological abuse
V61.21 Encounter for mental health services for victim of nonparental child sexual
abuse
V61.22 Encounter for mental health services for perpetrator of parental child abuse
V61.22 Encounter for mental health services for perpetrator of pa rental child neglect
V61.22 Encounter for mental health servic es for perpetrator of parental child
psychological abuse
V61.22 Encounter for mental health services for perpetrator of pa rental chil d sexual
abuse
V61.29 Child affected by parental relationship distress
V61.5 Problems related to multiparity
V61.7 Problems related to unwanted pregnancy
V61.8 High expressed emotion level within family
V61.8 Sibling relational problemICD-9-CM Disorder, cond ition, or problem | dsm5.pdf |
01e00b417c9a-0 | 876 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-9-CM)
V61.8 Upbringing away from parents
V62.21 Problem related to current military deployment status
V62.22 Exposure to disaster, war, or other hostilities
V62.22 Personal history of military deployment
V62.29 Other problem related to employment
V62.3 Academic or educational problem
V62.4 Acculturation difficulty
V62.4 Social exclusion or rejection
V62.4 Target of (perceived) advers e discrimination or persecution
V62.5 Conviction in civil or crimin al proceedings wi thout imprisonment
V62.5 Imprisonment or other incarceration
V62.5 Problems related to other legal circumstances
V62.5 Problems related to release from prison
V62.82 Uncomplicated bereavement
V62.83 Encounter for mental health services for perpetrator of nonparental child abuse
V62.83 Encounter for mental health servic es for perpetrator of nonparental child
neglect
V62.83 Encounter for mental health servic es for perpetrator of nonparental child
psychological abuse
V62.83 Encounter for mental health servic es for perpetrator of nonparental child
sexual abuse
V62.83 Encounter for mental health services for perpetrator of nonspousal adult abuse
V62.89 Borderline inte llectual functioning
V62.89 Discord with social service provider, including probation officer, case manager,
or social services worker
V62.89 Other problem related to psychosocial circumstances
V62.89 Phase of life problem
V62.89 Religious or spiritual problem
V62.89 Victim of crime
V62.89 Victim of terrorism or torture
V62.9 Unspecified problem related to social environment
V62.9 Unspecified problem related to unspecified psychosocial circumstances | dsm5.pdf |
01e00b417c9a-1 | V62.9 Unspecified problem related to unspecified psychosocial circumstances
V63.8 Unavailability or inaccessibility of other helping agencies
V63.9 Unavailability or inaccessibility of health care facilities
V65.2 Malingering
V65.40 Other counseling or consultation
V65.49 Encounter for mental health services for victim of nons pousal adult abuse
V65.49 Sex counseling
V69.9 Problem related to lifestyle
V71.01 Adult antisocial behavior
V71.02 Child or adolescent antisocial behaviorICD-9-CM Disorder, cond ition, or problem | dsm5.pdf |
1f10cd8a1d71-0 | 877Numerical Listing of
DSM-5 Diagnoses and Codes
(ICD-10-CM)
ICD-10-CM codes are to be us ed for coding purposes in the United States starting
October 1, 2014.
ICD-10-CM Disorder, co ndition, or problem
E66.9 Overweight or obesity
F01.50 Probable major vascular neurocognitive disorder, Without be havioral disturbance
F01.51 Probable major vascular neurocognitive di sorder, With beha vioral disturbance
F02.80 Major neurocognitive disorder du e to another medical condition, Without
behavioral disturbance
F02.80 Major neurocognitive disorder du e to HIV infection, Without behavioral
disturbance ( code first B20 HIV infection)
F02.80 Major neurocognitive disorder due to Hunting ton’s disease, Without
behavioral disturbance ( code first G10 Huntington’s disease)
F02.80 Major neurocognitive disorder due to multiple etio logies, Without behavioral
disturbance
F02.80 Major neurocognitive disorder probably due to Parkinson’s disease, Without
behavioral disturbance ( code first G20 Parkinson’s disease)
F02.80 Major neurocognitive disorder du e to prion disease, Without behavioral
disturbance ( code first A81.9 prion disease)
F02.80 Major neurocognitive disorder due to traumati c brain injury, Without
behavioral disturbance ( code first S06.2X9S diffuse traumatic brain injury
with loss of consciousness of unspecified duration, sequela)
F02.80 Probable major frontotemporal neuroc ognitive disorder, Without behavioral
disturbance ( code first G31.09 frontotemporal disease) | dsm5.pdf |
1f10cd8a1d71-1 | disturbance ( code first G31.09 frontotemporal disease)
F02.80 Probable major neurocognitive diso rder due to Alzheimer’s disease, Without
behavioral disturbance ( code first G30.9 Alzheimer’s disease)
F02.80 Probable major neurocognitive disorder with Lewy bodies, Without
behavioral disturbance ( code first G31.83 Lewy body disease)
F02.81 Major neurocognitive disorder du e to another medical condition, With
behavioral disturbance
F02.81 Major neurocognitive disorder du e to HIV infection, With behavioral
disturbance ( code first B20 HIV infection)
F02.81 Major neurocognitive disorder due to Huntington’s disease, With behavioral
disturbance ( code first G10 Huntington’s disease)
F02.81 Major neurocognitive disorder due to multiple etiologies, With behavioral
disturbance | dsm5.pdf |
6cd903b28c25-0 | 878 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F02.81 Major neurocognitive disorder probably due to Parkinson’s disease, With
behavioral disturbance ( code first G20 Parkinson’s disease)
F02.81 Major neurocognitive disorder du e to prion disease, With behavioral
disturbance ( code first A81.9 prion disease)
F02.81 Major neurocognitive di sorder due to traumatic brain injury, With behavioral
disturbance ( code first S06.2X9S diffuse traumatic brain injury with loss of
consciousness of unspecified duration, sequela)
F02.81 Probable major frontotemporal neur ocognitive disorder , With behavioral
disturbance ( code first G31.09 frontotemporal disease)
F02.81 Probable major neurocognitive diso rder due to Alzheimer’s disease, With
behavioral disturbance ( code first G30.9 Alzheimer’s disease)
F02.81 Probable major neurocognitive disord er with Lewy bodies, With behavioral
disturbance ( code first G31.83 Lewy body disease)
F05 Delirium due to another medical condition
F05 Delirium due to multiple etiologies
F06.0 Psychotic disorder due to another medical condition, With hallucinations
F06.1 Catatonia associated with another mental disord er (catatonia specifier)
F06.1 Catatonic disorder due to another medical condition
F06.1 Unspecified catatonia (code first R29.818 other symptoms involving nervous
and musculoskeletal systems)
F06.2 Psychotic disorder due to another medical condition, With delusions
F06.31 Depressive disorder due to another medical condition, With depressive features | dsm5.pdf |
6cd903b28c25-1 | F06.31 Depressive disorder due to another medical condition, With depressive features
F06.32 Depressive disorder due to anoth er medical condition, With major
depressive–like episode
F06.33 Bipolar and related disorder due to another medical condition, With manic features
F06.33 Bipolar and related disorder due to another medical condition, With manic- or
hypomanic-like episodes
F06.34 Bipolar and related disorder due to another medical condition, With mixed
features
F06.34 Depressive disorder due to another medical condition, With mixed features
F06.4 Anxiety disorder due to another medical condition
F06.8 Obsessive-compulsive and related disorder due to another medical condition
F06.8 Other specified mental disorder due to another medical condition
F07.0 Personality change due to another medical condition
F09 Unspecified mental disorder due to another medical condition
F10.10 Alcohol use disorder, Mild
F10.121 Alcohol intoxication deli rium, With mild use disorder
F10.129 Alcohol intoxication , With mild use disorder
F10.14 Alcohol-induced bipolar and related disorder, With mild use disorder
F10.14 Alcohol-induced depressive disorder, With mild use disorder
F10.159 Alcohol-induced psychotic disorder, With mild use disorder
F10.180 Alcohol-induced anxiety di sorder, With mild use disorder
F10.181 Alcohol-induced sexual dysfunction, With mild use disorder
F10.182 Alcohol-induced sleep disorder, With mild use disorder
F10.20 Alcohol use disorder, Moderate
F10.20 Alcohol use disorder, Severe
F10.221 Alcohol intoxication delirium, Wi th moderate or severe use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
b636bffe73c7-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 879
F10.229 Alcohol intoxicati on, With moderate or severe use disorder
F10.231 Alcohol withdrawal delirium
F10.232 Alcohol withdrawal, Wi th perceptual disturbances
F10.239 Alcohol withdrawal, With out perceptual disturbances
F10.24 Alcohol-induced bipolar and related disorder, With moderate or severe use
disorder
F10.24 Alcohol-induced depressive disorder, With moderate or severe use disorder
F10.259 Alcohol-induced psychotic disorder, With moderate or severe use disorder
F10.26 Alcohol-induced major neurocogniti ve disorder, Amnestic confabulatory
type, With moderate or severe use disorder
F10.27 Alcohol-induced major neurocogniti ve disorder, Nonamnestic confabulatory
type, With moderate or severe use disorder
F10.280 Alcohol-induced anxiety disorder, With moderate or severe use disorder
F10.281 Alcohol-induced sexual dysfunction, With moderate or severe use disorder
F10.282 Alcohol-induced sleep disorder, With moderate or severe use disorder
F10.288 Alcohol-induced mild neurocognitive disorder, With moderate or severe use
disorder
F10.921 Alcohol intoxication delirium, Without use disorder
F10.929 Alcohol intoxicati on, Without use disorder
F10.94 Alcohol-induced bipolar and related disorder, Without use disorder
F10.94 Alcohol-induced depressive disorder, Without use disorder
F10.959 Alcohol-induced psychotic disorder, Without use disorder
F10.96 Alcohol-induced major neurocogniti ve disorder, Amnestic confabulatory
type, Without use disorder
F10.97 Alcohol-induced major neurocogniti ve disorder, Nonamnestic confabulatory
type, Without use disorder
F10.980 Alcohol-induced anxiety disorder, Without use disorder | dsm5.pdf |
b636bffe73c7-1 | type, Without use disorder
F10.980 Alcohol-induced anxiety disorder, Without use disorder
F10.981 Alcohol-induced sexual dysfunction, Without use disorder
F10.982 Alcohol-induced sleep disorder, Without use disorder
F10.988 Alcohol-induced mild neurocognitive disorder, Without use disorder
F10.99 Unspecified alcohol-related disorder
F11.10 Opioid use disorder, Mild
F11.121 Opioid intoxication delirium, With mild use disorder
F11.122 Opioid intoxication, With perceptu al disturbances, With mild use disorder
F11.129 Opioid intoxication, Wi thout perceptual disturbanc es, With mild use disorder
F11.14 Opioid-induced depressive disorder, With mild use disorder
F11.181 Opioid-induced sexual dysfunction, With mild use disorder
F11.182 Opioid-induced sleep disorder, With mild use disorder
F11.188 Opioid-induced anxiety disorder, With mild use disorder
F11.20 Opioid use disorder, Moderate
F11.20 Opioid use disorder, Severe
F11.221 Opioid intoxication delirium, With moderate or severe use disorder
F11.222 Opioid intoxication, Wi th perceptual disturbances, With moderate or severe
use disorder
F11.229 Opioid intoxication, Without percep tual disturbances, With moderate or
severe use disorder
F11.23 Opioid withdrawal ICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
d60bbc55c1ef-0 | 880 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F11.23 Opioid with drawal delirium
F11.24 Opioid-induced depressive disorder, With moderate or severe use disorder
F11.281 Opioid-induced sexual dysfunction, With moderate or severe use disorder
F11.282 Opioid-induced sleep disorder, With moderate or severe use disorder
F11.288 Opioid-induced anxiet y disorder, With moderate or severe use disorder
F11.921 Opioid-induced delirium
F11.921 Opioid intoxication delirium, Without use disorder
F11.922 Opioid intoxication, With perceptual disturbances, Without use disorder
F11.929 Opioid intoxication, Without percep tual disturbances, Without use disorder
F11.94 Opioid-induced depressive disorder, Without use disorder
F11.981 Opioid-induced sexual dy sfunction, Without use disorder
F11.982 Opioid-induced sleep disorder, Without use disorder
F11.988 Opioid-induced anxiety disorder, Without use disorder
F11.99 Unspecified opioid-related disorder
F12.10 Cannabis use disorder, Mild
F12.121 Cannabis intoxication delirium, With mild use disorder
F12.122 Cannabis intoxication, With perceptu al disturbances, With mild use disorder
F12.129 Cannabis intoxication, Without percep tual disturbances, With mild use disorder
F12.159 Cannabis-induced psychotic disorder, With mild use disorder
F12.180 Cannabis-induced anxiety di sorder, With mild use disorder
F12.188 Cannabis-induced sleep disorder, With mild use disorder
F12.20 Cannabis use disorder, Moderate
F12.20 Cannabis use disorder, Severe
F12.221 Cannabis intoxication delirium, With moderate or severe use disorder | dsm5.pdf |
d60bbc55c1ef-1 | F12.221 Cannabis intoxication delirium, With moderate or severe use disorder
F12.222 Cannabis intoxication, Wi th perceptual dist urbances, With moderate or severe
use disorder
F12.229 Cannabis intoxication, Without perceptual disturbances, With moderate or
severe use disorder
F12.259 Cannabis-induced psychotic disorder, With moderate or severe use disorder
F12.280 Cannabis-induced anxiet y disorder, With moderate or severe use disorder
F12.288 Cannabis-induced sleep disorder, With moderate or severe use disorder
F12.288 Cannabis withdrawal
F12.921 Cannabis intoxication delirium, Without use disorder
F12.922 Cannabis intoxication, With perceptual disturbances, Without use disorder
F12.929 Cannabis intoxica tion, Without percep tual disturbances, Without use disorder
F12.959 Cannabis-induced psychotic disorder, Without use disorder
F12.980 Cannabis-induced anxiety disorder, Without use disorder
F12.988 Cannabis-induced sleep disorder, Without use disorder
F12.99 Unspecified cannabis-related disorder
F13.10 Sedative, hypnotic, or anxiolytic use disorder, Mild
F13.121 Sedative, hypnotic, or anxiolytic intoxication deli rium, With mild use disorder
F13.129 Sedative, hypnotic, or anxiolytic intoxication, With mild use disorder
F13.14 Sedative-, hypnotic-, or anxiolytic-i nduced bipolar and related disorder, With
mild use disorder
F13.14 Sedative-, hypnotic-, or anxiolytic-induced depressive disorder, With mild use
disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
3601037e9d75-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 881
F13.159 Sedative-, hypnotic-, or anxiolytic-induced psych otic disorder, With mild use
disorder
F13.180 Sedative-, hypnotic-, or anxiolytic -induced anxiety disorder, With mild use
disorder
F13.181 Sedative-, hypnotic-, or anxiolytic-induced sexual dysfunction, With mild use
disorder
F13.182 Sedative-, hypnotic-, or anxiolytic-ind uced sleep disorder, Wi th mild use disorder
F13.20 Sedative, hypnotic, or an xiolytic use disorder, Moderate
F13.20 Sedative, hypnotic, or an xiolytic use disorder, Severe
F13.221 Sedative, hypnotic, or anxiolytic in toxication delirium, With moderate or
severe use disorder
F13.229 Sedative, hypnotic, or anxiolytic intoxication, With mo derate or severe use disorder
F13.231 Sedative, hypnotic, or an xiolytic withdrawal delirium
F13.232 Sedative, hypnotic, or anxiolytic withdr awal, With perceptual disturbances
F13.239 Sedative, hypnotic, or anxiolytic wi thdrawal, Without perceptual disturbances
F13.24 Sedative-, hypnotic-, or anxiolytic-induced bipolar and related disorder, With
moderate or severe use disorder
F13.24 Sedative-, hypnotic-, or anxiolytic-induced depressive disorder, With
moderate or severe use disorder
F13.259 Sedative-, hypnotic-, or anxiolytic-induced psychotic disorder, With moderate
or severe use disorder | dsm5.pdf |
3601037e9d75-1 | or severe use disorder
F13.27 Sedative-, hypnotic-, or anxiolytic -induced major neurocognitive disorder,
With moderate or severe use disorder
F13.280 Sedative-, hypnotic-, or anxiolytic-i nduced anxiety disorder, With moderate or
severe use disorder
F13.281 Sedative-, hypnotic-, or anxiolytic-induced sexual dysfunction, With moderate
or severe use disorder
F13.282 Sedative-, hypnotic-, or anxiolytic-induced sleep disorder, With moderate or
severe use disorder
F13.288 Sedative-, hypnotic-, or anxiolytic -induced mild neuroc ognitive disorder,
With moderate or severe use disorder
F13.921 Sedative-, hypnotic-, or anxiolytic-induced delirium
F13.921 Sedative, hypnotic, or anxiolytic in toxication delirium, Without use disorder
F13.929 Sedative, hypnotic, or anxiolyt ic intoxication, Without use disorder
F13.94 Sedative-, hypnotic-, or anxiolytic-induced bipolar and related disorder,
Without use disorder
F13.94 Sedative-, hypnotic-, or anxiolytic -induced depressive disorder, Without use
disorder
F13.959 Sedative-, hypnotic-, or anxiolytic -induced psychotic disorder, Without use
disorder
F13.97 Sedative-, hypnotic-, or anxiolytic -induced major neurocognitive disorder,
Without use disorder
F13.980 Sedative-, hypnotic-, or anxiolytic-i nduced anxiety disorder, Without use disorder
F13.981 Sedative-, hypnotic-, or anxiolytic -induced sexual dysfunction, Without use
disorder | dsm5.pdf |
3601037e9d75-2 | disorder
F13.982 Sedative-, hypnotic-, or anxiolytic-i nduced sleep disorder, Without use disorder
F13.988 Sedative-, hypnotic-, or anxiolytic -induced mild neuroc ognitive disorder,
Without use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
da701a1324ba-0 | 882 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F13.99 Unspecified sedative-, hypnotic-, or anxiolytic-related disorder
F14.10 Cocaine use disorder, Mild
F14.121 Cocaine intoxication delirium, With mild use disorder
F14.122 Cocaine intoxication, With perceptual disturbances, With mild use disorder
F14.129 Cocaine intoxication, Wi thout perceptual disturbances, With mild use disorder
F14.14 Cocaine-induced bipolar and related disorder, With mild use disorder
F14.14 Cocaine-induced depressive disorder, With mild use disorder
F14.159 Cocaine-induced psychotic disorder, With mild use disorder
F14.180 Cocaine-induced anxiety disorder, With mild use disorder
F14.181 Cocaine-induced sexual dysfunction, With mild use disorder
F14.182 Cocaine-induced sleep disorder, With mild use disorder
F14.188 Cocaine-induced obsessive-compulsive and related disorder, With mild use
disorder
F14.20 Cocaine use disorder, Moderate
F14.20 Cocaine use disorder, Severe
F14.221 Cocaine intoxication delirium, With moderate or severe use disorder
F14.222 Cocaine intoxication, Wi th perceptual disturbances, With moderate or severe
use disorder
F14.229 Cocaine intoxication, Without perceptual disturbances, With moderate or
severe use disorder
F14.23 Cocaine withdrawal
F14.24 Cocaine-induced bipolar and related disorder, With moderate or severe use
disorder
F14.24 Cocaine-induced depressive disorder, With moderate or severe use disorder
F14.259 Cocaine-induced psychotic disorder, With moderate or severe use disorder
F14.280 Cocaine-induced anxiety disorder, With moderate or severe use disorder | dsm5.pdf |
da701a1324ba-1 | F14.280 Cocaine-induced anxiety disorder, With moderate or severe use disorder
F14.281 Cocaine-induced sexual dysfunction, With moderate or severe use disorder
F14.282 Cocaine-induced sleep disorder, With moderate or severe use disorder
F14.288 Cocaine-induced obsessive-compulsive and related disorder, With moderate
or severe use disorder
F14.921 Cocaine intoxication de lirium, Without use disorder
F14.922 Cocaine intoxication, With perceptual disturba nces, Without use disorder
F14.929 Cocaine intoxication, Without perceptual disturba nces, Without use disorder
F14.94 Cocaine-induced bipolar and related disorder, Without use disorder
F14.94 Cocaine-induced depressive disorder, Without use disorder
F14.959 Cocaine-induced psychotic disorder, Without use disorder
F14.980 Cocaine-induced anxiety disorder, Without use disorder
F14.981 Cocaine-induced sexual dysfunction, Without use disorder
F14.982 Cocaine-induced sleep disorder, Without use disorder
F14.988 Cocaine-induced obsessive-compulsive and related disorder, Without use disorder
F14.99 Unspecified stimulant-related disorder, Unspecified Cocaine-related disorder
F15.10 Amphetamine-type su bstance use disorder, Mild
F15.10 Other or unspecified stimulant use disorder, Mild
F15.121 Amphetamine (or other stimulant) intoxication delirium, With mild use disorder
F15.122 Amphetamine or other stimulant intoxication, With perceptual disturbances,
With mild use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
1218c2ff7ddf-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 883
F15.129 Amphetamine or ot her stimulant intoxicatio n, Without perceptual
disturbances, With mild use disorder
F15.14 Amphetamine (or other stimulant)–i nduced bipolar and related disorder,
With mild use disorder
F15.14 Amphetamine (or other stimulant)–induced depressive disorder, With mild
use disorder
F15.159 Amphetamine (or other stimulant)–ind uced psychotic disorder, With mild use
disorder
F15.180 Amphetamine (or other stimulant)–i nduced anxiety disorder, With mild use
disorder
F15.180 Caffeine-induced anxiety disorder, With mild use disorder
F15.181 Amphetamine (or other stimulant)–induced sexual dysfunction, With mild
use disorder
F15.182 Amphetamine (or other stimulant)–induc ed sleep disorder, With mild use disorder
F15.182 Caffeine-induced sleep disorder, With mild use disorder
F15.188 Amphetamine (or other stimulant)–induced obsessive-compulsive and related
disorder, With mild use disorder
F15.20 Amphetamine-type subs tance use disorder, Moderate
F15.20 Amphetamine-type subs tance use disorder, Severe
F15.20 Other or unspecified st imulant use disorder, Moderate
F15.20 Other or unspecified st imulant use disorder, Severe
F15.221 Amphetamine (or other stimulant) intoxication delirium, With moderate or
severe use disorder
F15.222 Amphetamine or other stimulant intoxication, With perceptual disturbances,
With moderate or severe use disorder | dsm5.pdf |
1218c2ff7ddf-1 | With moderate or severe use disorder
F15.229 Amphetamine or ot her stimulant intoxicatio n, Without perceptual
disturbances, With moderate or severe use disorder
F15.23 Amphetamine or ot her stimulan t withdrawal
F15.24 Amphetamine (or other stimulant)–i nduced bipolar and related disorder,
With moderate or severe use disorder
F15.24 Amphetamine (or other stimulant) –induced depressive disorder, With
moderate or severe use disorder
F15.259 Amphetamine (or other stimulant) –induced psychoti c disorder, With
moderate or severe use disorder
F15.280 Amphetamine (or other stimulant)–induced anxiety disorder, With moderate
or severe use disorder
F15.280 Caffeine-induced anxiety disorder, With moderate or severe use disorder
F15.281 Amphetamine (or other stimulant)–induced sexual dy sfunction, With
moderate or severe use disorder
F15.282 Amphetamine (or other stimulant)–induced sleep disorder, With moderate or
severe use disorder
F15.282 Caffeine-induced sleep disorder, With moderate or severe use disorder
F15.288 Amphetamine (or other stimulant)–induced obsessive-compulsive and related
disorder, With moderate or severe use disorder
F15.921 Amphetamine (or other stimulant)–induced delirium
F15.921 Amphetamine (or other stimulant) intoxication deli rium, Without use disorder
F15.922 Amphetamine or other stimulant intoxication, With perceptual disturbances,
Without use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
cdcf0f153ff3-0 | 884 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F15.929 Amphetamine or ot her stimulant intoxicatio n, Without perceptual
disturbances, Without use disorder
F15.929 Caffeine intoxication
F15.93 Caffeine withdrawal
F15.94 Amphetamine (or other stimulant)–i nduced bipolar and related disorder,
Without use disorder
F15.94 Amphetamine (or other stimulant)–induced depressive disorder, Without use
disorder
F15.959 Amphetamine (or other stimulant)–i nduced psychotic disorder, Without use
disorder
F15.980 Amphetamine (or other stimulant)–i nduced anxiety disorder, Without use
disorder
F15.980 Caffeine-induced anxiety disorder, Without use disorder
F15.981 Amphetamine (or other stimulant)–induced sexual dysfunction, Without use
disorder
F15.982 Amphetamine (or other stimulant)–ind uced sleep disorder, Without use disorder
F15.982 Caffeine-induced sleep disorder, Without use disorder
F15.988 Amphetamine (or other stimulant)–induced obsessive-compulsive and related
disorder, Without use disorder
F15.99 Unspecified amphetamine or other stimulant-related disorder
F15.99 Unspecified caffeine-related disorder
F16.10 Other hallucinogen use disorder, Mild
F16.10 Phencyclidine use disorder, Mild
F16.121 Other hallucinogen intoxication delirium, With mild use disorder
F16.121 Phencyclidine intoxication delirium, With mild use disorder
F16.129 Other hallucinogen intoxi cation, With mi ld use disorder | dsm5.pdf |
cdcf0f153ff3-1 | F16.129 Other hallucinogen intoxi cation, With mi ld use disorder
F16.129 Phencyclidine intoxication, With mild use disorder
F16.14 Other hallucinogen–induced bipolar and related disorder, With mild use disorder
F16.14 Other hallucinogen–ind uced depressive disorder, With mild use disorder
F16.14 Phencyclidine-induced bipolar and related disorder, With mild use disorder
F16.14 Phencyclidine-induced depressive disorder, With mild use disorder
F16.159 Other hallucinogen–i nduced psychotic disorder, With mild use disorder
F16.159 Phencyclidine-induced psychotic disorder, With mild use disorder
F16.180 Other hallucinogen–i nduced anxiety disorder, With mild use disorder
F16.180 Phencyclidine-indu ced anxiety disorder, With mild use disorder
F16.20 Other hallucinogen use disorder, Moderate
F16.20 Other hallucinogen use disorder, Severe
F16.20 Phencycl idine use disorder, Moderate
F16.20 Phencyclidine use disorder, Severe
F16.221 Other hallucinogen intoxication delirium, With moderate or severe use disorder
F16.221 Phencyclidine intoxication delirium, With moderate or severe use disorder
F16.229 Other hallucinogen intoxication, With moderate or severe use disorder
F16.229 Phencyclidine intoxication, With moderate or severe use disorder
F16.24 Other hallucinogen–ind uced bipolar and related disorder, With moderate or
severe use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
65be08cff400-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 885
F16.24 Other hallucinogen–ind uced depressive disorder, With moderate or severe
use disorder
F16.24 Phencyclidine-induced bipolar and related disorder, With moderate or severe
use disorder
F16.24 Phencyclidine-induced depressive disord er, With moderate or severe use disorder
F16.259 Other hallucinog en–induced psychotic disorder, With moderate or severe use
disorder
F16.259 Phencyclidine-induced psychotic disord er, With moderate or severe use disorder
F16.280 Other hallucinogen–ind uced anxiety disorder, With moderate or severe use
disorder
F16.280 Phencyclidine-induced anxiety disorder, With moderate or severe use disorder
F16.921 Other hallucinogen intoxication delirium, Without use disorder
F16.921 Phencyclidine intoxication delirium, Without use disorder
F16.929 Other hallucinogen intoxication, Without use disorder
F16.929 Phencyclidine intoxicat ion, Without use disorder
F16.94 Other hallucinogen–induced bipolar and related disorder, Without use disorder
F16.94 Other hallucinogen–i nduced depressive disorder, Without use disorder
F16.94 Phencyclidine-induced bipolar and related disorder, Without use disorder
F16.94 Phencyclidine-induced depressive disorder, Without use disorder
F16.959 Other hallucinogen–i nduced psychotic disord er, Without use disorder
F16.959 Phencyclidine-induced psychotic disorder, Without use disorder
F16.980 Other hallucinogen –induced anxiety disord er, Without use disorder
F16.980 Phencyclidine-in duced anxiety disorder , Without use disorder | dsm5.pdf |
65be08cff400-1 | F16.980 Phencyclidine-in duced anxiety disorder , Without use disorder
F16.983 Hallucinogen persisting perception disorder
F16.99 Unspecified halluc inogen-related disorder
F16.99 Unspecified phencyclidine-related disorder
F17.200 Tobacco use disorder, Moderate
F17.200 Tobacco use disorder, Severe
F17.203 Tobacco withdrawal
F17.208 Tobacco-induced sleep disorder, Wi th moderate or severe use disorder
F17.209 Unspecified tobac co-related disorder
F18.10 Inhalant use disorder, Mild
F18.121 Inhalant intoxication delirium, With mild use disorder
F18.129 Inhalant intoxication, With mild use disorder
F18.14 Inhalant-induced depressive disorder, With mild use disorder
F18.159 Inhalant-induced psychotic disorder, With mild use disorder
F18.17 Inhalant-induced major neurocogni tive disorder, With mild use disorder
F18.180 Inhalant-induced anxiety di sorder, With mild use disorder
F18.188 Inhalant-induced mild neurocognitive disorder, With mild use disorder
F18.20 Inhalant use disorder, Moderate
F18.20 Inhalant use disorder, Severe
F18.221 Inhalant intoxication delirium, With moderate or severe use disorder
F18.229 Inhalant intoxication, With moderate or severe use disorder
F18.24 Inhalant-induced depressive disorder, With moderate or severe use disorder
F18.259 Inhalant-induced psychotic disorder, With moderate or severe use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
04001230c6c9-0 | 886 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F18.27 Inhalant-induced major neurocognitive disorder, With moderate or severe use
disorder
F18.280 Inhalant-induced anxiety disorder, With moderate or severe use disorder
F18.288 Inhalant-induced mild neurocognitive disorder, With mode rate or severe use
disorder
F18.921 Inhalant intoxication delirium, Without use disorder
F18.929 Inhalant intoxicatio n, Without use disorder
F18.94 Inhalant-induced depressive disorder, Without use disorder
F18.959 Inhalant-induced psychotic disorder, Without use disorder
F18.97 Inhalant-induced major neurocog nitive disorder, Wi thout use disorder
F18.980 Inhalant-induced anxiety disorder, Without use disorder
F18.988 Inhalant-induced mild neurocogni tive disorder, Without use disorder
F18.99 Unspecified inhalant-related disorder
F19.10 Other (or unknown) su bstance use disorder, Mild
F19.121 Other (or unknown) substance intoxi cation delirium, With mild use disorder
F19.129 Other (or unknown) substance in toxication, With mild use disorder
F19.14 Other (or unknown) substance–induced bipolar and related disorder, With
mild use disorder
F19.14 Other (or unknown) substance–induced depressive disorder, With mild use
disorder
F19.159 Other (or unknown) substance–indu ced psychotic disorder, With mild use
disorder
F19.17 Other (or unknown) substance–induce d major neurocogniti ve disorder, With
mild use disorder
F19.180 Other (or unknown) substance–induced anxiety disorder, With mild use disorder | dsm5.pdf |
04001230c6c9-1 | F19.181 Other (or unknown) substance–induced sexual dysfunction, With mild use
disorder
F19.182 Other (or unknown) substance–induced sleep disorder, With mild use disorder
F19.188 Other (or unknown) substance–induce d mild neurocognitive disorder, With
mild use disorder
F19.188 Other (or unknown) substance–induced obsessive-compulsive and related
disorder, With mild use disorder
F19.20 Other (or unknown) substance use disorder, Moderate
F19.20 Other (or unknown) su bstance use disorder, Severe
F19.221 Other (or unknown) subs tance intoxication delirium, With moderate or severe
use disorder
F19.229 Other (or unknown) substance intoxication, With moderate or severe use disorder
F19.231 Other (or unknown) su bstance withdrawal delirium
F19.239 Other (or unknown) substance withdrawal
F19.24 Other (or unknown) substance–induced bipolar and related disorder, With
moderate or seve re use disorder
F19.24 Other (or unknown) substance–induced depressive disorder, With moderate
or severe use disorder
F19.259 Other (or unknown) substance–induce d psychotic disorder, With moderate or
severe use disorder
F19.27 Other (or unknown) substance–induce d major neurocogniti ve disorder, With
moderate or seve re use disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
419497a915bd-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 887
F19.280 Other (or unknown) substance–induce d anxiety disorder, With moderate or
severe use disorder
F19.281 Other (or unknown) substance–induced sexual dysfunction, With moderate or
severe use disorder
F19.282 Other (or unknown) substance–indu ced sleep disorder, With moderate or
severe use disorder
F19.288 Other (or unknown) substance–induce d mild neurocognitive disorder, With
moderate or severe use disorder
F19.288 Other (or unknown) substance–induced obsessive-compulsive and related
disorder, With moderate or severe use disorder
F19.921 Other (or unknown) substance–induced delirium
F19.921 Other (or unknown) substance into xication delirium, Without use disorder
F19.929 Other (or unknown) substance intoxication, With out use disorder
F19.94 Other (or unknown) substance–induced bipolar and related disorder, Without
use disorder
F19.94 Other (or unknown) subs tance–induced depressive disorder, Without use disorder
F19.959 Other (or unknown) substance–induced psychotic disorder, Without use disorder
F19.97 Other (or unknown) substance–in duced major neurocognitive disorder,
Without use disorder
F19.980 Other (or unknown) substance–induced anxiety disorder, Without use disorder
F19.981 Other (or unknown) substance–induced sexual dysfunction, Without use disorder
F19.982 Other (or unknown) substance–indu ced sleep disorder, Without use disorder
F19.988 Other (or unknown) substance–induced mild neurocognitive disorder,
Without use disorder | dsm5.pdf |
419497a915bd-1 | Without use disorder
F19.988 Other (or unknown) substance–induced obsessive-compulsive and related
disorder, Without use disorder
F19.99 Unspecified other (or unknow n) substance–related disorder
F20.81 Schizophreniform disorder
F20.9 Schizophrenia
F21 Schizotypal personality disorder
F22 Delusional disorder
F23 Brief psychotic disorder
F25.0 Schizoaffective disorder, Bipolar type
F25.1 Schizoaffective disorder, Depressive type
F28 Other specified schizophrenia sp ectrum and other psychotic disorder
F29 Unspecified schizophrenia spec trum and other psychotic disorder
F31.0 Bipolar I disorder, Current or most recent episode hypomanic
F31.11 Bipolar I disorder , Current or most rece nt episode manic, Mild
F31.12 Bipolar I disorder, Current or most recent episode manic, Moderate
F31.13 Bipolar I disorder, Current or most recent episode manic, Severe
F31.2 Bipolar I disorder, Current or most re cent episode manic, Wi th psychotic features
F31.31 Bipolar I disorder, Current or most recent episode depressed, Mild
F31.32 Bipolar I disorder, Cu rrent or most recent episode depressed, Moderate
F31.4 Bipolar I disorder, Current or mo st recent episode depressed, Severe
F31.5 Bipolar I disorder, Current or most recent episode depressed, With psychotic
featuresICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
fae2a7e32c59-0 | 888 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F31.71 Bipolar I disorder, Current or most rece nt episode hypomanic, In partial remission
F31.72 Bipolar I disorder, Curr ent or most recent episode hypomanic, In full remission
F31.73 Bipolar I disorder, Curre nt or most recent episode manic, In partial remission
F31.74 Bipolar I disorder, Curre nt or most recent episode manic, In full remission
F31.75 Bipolar I disorder, Current or most recent episode depressed, In partial remission
F31.76 Bipolar I disorder, Current or most recent episode depressed, In full remission
F31.81 Bipolar II disorder
F31.89 Other specified bipolar and related disorder
F31.9 Bipolar I disorder, Current or most recent episode depressed, Unspecified
F31.9 Bipolar I disorder, Current or most recent episode hypomanic, Unspecified
F31.9 Bipolar I disorder, Current or mo st recent episode manic, Unspecified
F31.9 Bipolar I disorder, Current or most recent episode unspecified
F31.9 Unspecified bipolar and related disorder
F32.0 Major depressive disorder, Single episode, Mild
F32.1 Major depressive disorder, Single episode, Moderate
F32.2 Major depressive disorder, Single episode, Severe
F32.3 Major depressive disorder, Single episode, With psychotic features
F32.4 Major depressive disorder, Single episode, In partial remission
F32.5 Major depressive disorder, Single episode, In full remission
F32.8 Other specified depressive disorder
F32.9 Major depressive disorder, Single episode, Unspecifed
F32.9 Unspecified depressive disorder | dsm5.pdf |
fae2a7e32c59-1 | F32.9 Unspecified depressive disorder
F33.0 Major depressive disorde r, Recurrent episode, Mild
F33.1 Major depressive disorder, Recurrent episode, Moderate
F33.2 Major depressive disorder, Recurrent episode, Severe
F33.3 Major depressive disorder, Recurre nt episode, With psychotic features
F33.41 Major depressive disorder, Recurrent episode, In partial remission
F33.42 Major depressive disorder, Recurrent episode, In full remission
F33.9 Major depressive disorder, Recurrent episode, Unspecified
F34.0 Cyclothymic disorder
F34.1 Persistent depressi ve disorder (dysthymia)
F34.8 Disruptive mood dysregulation disorder
F40.00 Agoraphobia
F40.10 Social anxiety disorder (social phobia)
F40.218 Specific phobia, Animal
F40.228 Specific phobia, Natural environment
F40.230 Specific phobia, Fear of blood
F40.231 Specific phobia, Fear of injections and transfusions
F40.232 Specific phobia, Fear of other medical care
F40.233 Specific phobia, Fear of injury
F40.248 Specific phobia, Situational
F40.298 Specific phobia, Other
F41.0 Panic disorder
F41.1 Generalized anxiety disorder
F41.8 Other specified anxiety disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
0a507111de98-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 889
F41.9 Unspecified anxiety disorder
F42 Hoarding disorder
F42 Obsessive-compulsive disorder
F42 Other specified obsessive-compulsive and related disorder
F42 Unspecified obsessive-compulsive and related disorder
F43.0 Acute stress disorder
F43.10 Posttraumatic stress disorder
F43.20 Adjustment disorders, Unspecified
F43.21 Adjustment disorder s, With depressed mood
F43.22 Adjustment diso rders, With anxiety
F43.23 Adjustment disorders, With mixed anxiety and depressed mood
F43.24 Adjustment disorders, With disturbance of conduct
F43.25 Adjustment disorders, With mixed disturbance of emotions and conduct
F43.8 Other specified trauma- and stressor-related disorder
F43.9 Unspecified trauma- an d stressor-related disorder
F44.0 Dissociative amnesia
F44.1 Dissociative amnesia, With dissociative fugue
F44.4 Conversion disorder (functional ne urological symptom disorder), With
abnormal movement
F44.4 Conversion disorder (functional ne urological symptom disorder), With
speech symptoms
F44.4 Conversion disorder (functional ne urological symptom disorder), With
swallowing symptoms
F44.4 Conversion disorder (functional ne urological symptom disorder), With
weakness/paralysis
F44.5 Conversion disorder (functional ne urological symptom disorder), With
attacks or seizures
F44.6 Conversion disorder (functional ne urological symptom disorder), With
anesthesia or sensory loss
F44.6 Conversion disorder (functional ne urological symptom disorder), With
special sensory symptoms
F44.7 Conversion disorder (functional neurological symptom disorder), With mixed
symptoms | dsm5.pdf |
0a507111de98-1 | F44.7 Conversion disorder (functional neurological symptom disorder), With mixed
symptoms
F44.81 Dissociative identity disorder
F44.89 Other specified dissociative disorder
F44.9 Unspecified diss ociative disorder
F45.1 Somatic sy mptom disorder
F45.21 Illness anxiety disorder
F45.22 Body dysmorphic disorder
F45.8 Other specified somatic symptom and related disorder
F45.9 Unspecified somatic symptom and related disorder
F48.1 Depersonalization/ derealization disorder
F50.01 Anorexia nervosa, Restricting type
F50.02 Anorexia nervosa, Binge-eating/purging type
F50.2 Bulimia nervosa
F50.8 Avoidant/restrictive food intake disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
bc12d37c8601-0 | 890 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F50.8 Binge-eating disorder
F50.8 Other specified feeding or eating disorder
F50.8 Pica, in adults
F50.9 Unspecified feeding or eating disorder
F51.01 Insomnia disorder
F51.11 Hypersomno lence disorder
F51.3 Non–rapid eye movement sleep arousal disorders, Sleepwalking type
F51.4 Non–rapid eye movement sleep arousal disorders, Sleep terror type
F51.5 Nightmare disorder
F52.0 Male hypoactive se xual desire disorder
F52.21 Erectile disorder
F52.22 Female sexual in terest/arous al disorder
F52.31 Female orgasmic disorder
F52.32 Delayed ejaculation
F52.4 Premature (early) ejaculation
F52.6 Genito-pelvic pain /penetration disorder
F52.8 Other specified sexual dysfunction
F52.9 Unspecified sexual dysfunction
F54 Psychological factors affe cting other medical conditions
F60.0 Paranoid personality disorder
F60.1 Schizoid personality disorder
F60.2 Antisocial personality disorder
F60.3 Borderline personality disorder
F60.4 Histrionic personality disorder
F60.5 Obsessive-compulsiv e personality disorder
F60.6 Avoidant personality disorder
F60.7 Dependent personality disorder
F60.81 Narcissistic personality disorder
F60.89 Other specified personality disorder
F60.9 Unspecified pe rsonality disorder
F63.0 Gambling disorder
F63.1 Pyromania
F63.2 Kleptomania
F63.3 Trichotillomania (hair-pulling disorder)
F63.81 Intermittent explosive disorder | dsm5.pdf |
bc12d37c8601-1 | F63.81 Intermittent explosive disorder
F64.1 Gender dysphoria in adolescents and adults
F64.2 Gender dysphoria in children
F64.8 Other specified gender dysphoria
F64.9 Unspecified gender dysphoria
F65.0 Fetishistic disorder
F65.1 Transvestic disorder
F65.2 Exhibitionistic disorder
F65.3 Voyeuristic disorder
F65.4 Pedophilic disorder
F65.51 Sexual ma sochism disorder
F65.52 Sexual sadism disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
0733103b9ce4-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 891
F65.81 Frotteuristic disorder
F65.89 Other specified paraphilic disorder
F65.9 Unspecified pa raphilic disorder
F68.10 Factitious disorder
F70 Intellectual disability (intellectual developmental disorder), Mild
F71 Intellectual disability (intellectual developmental disorder), Moderate
F72 Intellectual disability (intellectual developmental disorder), Severe
F73 Intellectual disability (intellectual developmental disorder), Profound
F79 Unspecified intellectual disability (intellectual developmental disorder)
F80.0 Speech sound disorder
F80.2 Language disorder
F80.81 Childhood-onset flue ncy disorder (stuttering)
F80.89 Social (pragmatic ) communication disorder
F80.9 Unspecified communication disorder
F81.0 Specific learning disorder , With impairment in reading
F81.2 Specific learning disorder, With impairment in mathematics
F81.81 Specific learning disorder, With impairment in written expression
F82 Developmental coordination disorder
F84.0 Autism spectrum disorder
F88 Global developmental delay
F88 Other specified neurodevelopmental disorder
F89 Unspecified neurod evelopmental disorder
F90.0 Attention-deficit/hyperactivity disord er, Predominantly inattentive presentation
F90.1 Attention-deficit/hyperactivity disorder, Predominantly hyperactive/
impulsive presentation
F90.2 Attention-deficit/hyperactivity disorder, Combined presentation
F90.8 Other specified attention- deficit/hyperactivity disorder
F90.9 Unspecified attention-de ficit/hyperactivity disorder
F91.1 Conduct disorder, Childhood-onset type
F91.2 Conduct disorder, Adolescent-onset type
F91.3 Oppositional defiant disorder | dsm5.pdf |
0733103b9ce4-1 | F91.3 Oppositional defiant disorder
F91.8 Other specified disruptive, impulse-control, and conduct disorder
F91.9 Conduct disorder, Unspecified onset
F91.9 Unspecified disruptive, impulse-control, and conduct disorder
F93.0 Separation anxiety disorder
F94.0 Selective mutism
F94.1 Reactive attachment disorder
F94.2 Disinhibited social engagement disorder
F95.0 Provisional tic disorder
F95.1 Persistent (chronic) motor or vocal tic disorder
F95.2 Tourette’s disorder
F95.8 Other specified tic disorder
F95.9 Unspecified tic disorder
F98.0 Enuresis
F98.1 Encopresis
F98.21 Rumination disorderICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
4a46e1901282-0 | 892 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
F98.3 Pica, in children
F98.4 Stereotypic movement disorder
F98.5 Adult-onset fluency disorder
F99 Other specified mental disorder
F99 Unspecified mental disorder
G21.0 Neuroleptic malignant syndrome
G21.11 Neuroleptic-induced parkinsonism
G21.19 Other medication -induced parkinsonism
G24.01 Tardive dyskinesia
G24.02 Medication-ind uced acute dystonia
G24.09 Tardive dystonia
G25.1 Medication-induced postural tremor
G25.71 Medication-induc ed acute akathisia
G25.71 Tardiv e akathisia
G25.79 Other medication-induced movement disorder
G25.81 Restless legs syndrome
G31.84 Mild frontotemporal neurocognitive disorder
G31.84 Mild neurocogni tive disorder due to Alzheimer’s disease
G31.84 Mild neurocogniti ve disorder due to another medical condition
G31.84 Mild neurocognitive di sorder due to HIV infection
G31.84 Mild neurocogni tive disorder due to Huntington’s disease
G31.84 Mild neurocognitive disorder with Lewy bodies
G31.84 Mild neurocognitive disorder due to multiple etiologies
G31.84 Mild neurocogni tive disorder due to Parkinson’s disease
G31.84 Mild neurocognitive di sorder due to prion disease
G31.84 Mild neurocognitive disord er due to traumatic brain injury
G31.84 Mild vascular ne urocognitive disorder
G31.9 Major neurocognitive disorder possibly due to Parkinson’s disease | dsm5.pdf |
4a46e1901282-1 | G31.9 Major neurocognitive disorder possibly due to Parkinson’s disease
G31.9 Possible major frontotemp oral neurocognitive disorder
G31.9 Possible major neurocognitive disorder due to Alzheimer’s disease
G31.9 Possible major neurocogniti ve disorder wi th Lewy bodies
G31.9 Possible major vascular neurocogniti ve disorder
G47.00 Unspecified insomnia disorder
G47.09 Other specified insomnia disorder
G47.10 Unspecified hypersomnolence disorder
G47.19 Other specified hypersomnolence disorder
G47.20 Circadian rhythm sleep-wak e disorders, Unspecified type
G47.21 Circadian rhythm sleep-wake di sorders, Delayed sleep phase type
G47.22 Circadian rhythm sleep-wake di sorders, Advanced sleep phase type
G47.23 Circadian rhythm sleep-wake di sorders, Irregula r sleep-wake type
G47.24 Circadian rhythm sleep-wake di sorders, Non-24-hour sleep-wake type
G47.26 Circadian rhythm sleep-wak e disorders, Shift work type
G47.31 Central sleep apnea, Id iopathic central sleep apneaICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
900fbdea249d-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 893
G47.33 Obstructive sleep apnea hypopnea
G47.34 Sleep-related hypoventilation, Idiopathic hypoventilation
G47.35 Sleep-related hypoventilation, Cong enital central alveolar hypoventilation
G47.36 Sleep-related hypoventilation, Comorbid sleep-related hypoventilation
G47.37 Central sleep apnea comorbid with opioid use
G47.411 Narcolepsy with cataplexy but without hypocretin deficiency
G47.419 Autosomal dominant cerebellar ataxia, deafness, and narcolepsy
G47.419 Autosomal dominant narcolep sy, obesity, and type 2 diabetes
G47.419 Narcolepsy without cataple xy but with hypocretin deficiency
G47.429 Narcolepsy secondary to another medical condition
G47.52 Rapid eye movement sleep behavior disorder
G47.8 Other specified sleep-wake disorder
G47.9 Unspecified sleep-wake disorder
L98.1 Excoriation (skin-picking) disorder
N39.498 Other specified elimination disorder, With urinary symptoms
N94.3 Premenstrual dysphoric disorder
R06.3 Central sleep apnea, Cheyne-Stokes breathing
R15.9 Other specified elimination disorder, With fecal symptoms
R15.9 Unspecified elimination disorder, With fecal symptoms
R32 Unspecified elimination disorder, With urinary symptoms
R41.0 Other specified delirium
R41.0 Unspecified delirium
R41.83 Borderline intellectual functioning
R41.9 Unspecified neur ocognitive disorder
T43.205A Antidepressant discontinuation syndrome, Initial encounter | dsm5.pdf |
900fbdea249d-1 | T43.205A Antidepressant discontinuation syndrome, Initial encounter
T43.205D Antidepressant discontinuation syndrome, Subsequent encounter
T43.205S Antidepressant discont inuation syndrome, Sequelae
T50.905A Other adverse effect of medication, Initial encounter
T50.905D Other adverse effect of medication, Subsequent encounter
T50.905S Other adverse effect of medication, Sequelae
T74.01XA Spouse or partner neglect, Confirmed, Initial encounter
T74.01XD Spouse or partner neglect, Confirmed, Subsequent encounter
T74.02XA Child neglect, Confirmed, Initial encounter
T74.02XD Child neglect, Confirmed, Subsequent encounter
T74.11XA Adult physical abuse by nonspouse or nonpartner, Confirme d, Initial encounter
T74.11XA Spouse or partner violence, Physical, Confirmed, Initial encounter
T74.11XD Adult physical abus e by nonspouse or nonpartn er, Confirmed, Subsequent
encounter
T74.11XD Spouse or partner violence, Phys ical, Confirmed, Subsequent encounter
T74.12XA Child physical abuse, Confirmed, Initial encounter
T74.12XD Child physical abuse, Confirmed, Subsequent encounter
T74.21XA Adult sexual abuse by nonspouse or nonpartner, Confirmed, Initial encounter
T74.21XA Spouse or partner violence, Sexual, Confirmed, Initial encounter
T74.21XD Adult sexual abuse by nonspouse or nonpartner, Confirmed, Subsequent
encounterICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
45e838104c6b-0 | 894 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
T74.21XD Spouse or partner violence, Se xual, Confirmed, Subsequent encounter
T74.22XA Child sexual abuse, Confirmed, Initial encounter
T74.22XD Child sexual abuse, Confirmed, Subsequent encounter
T74.31XA Adult psychological abuse by nonspouse or nonpartner, Confirmed, Initial
encounter
T74.31XA Spouse or partner abuse, Psycho logical, Confirmed, Initial encounter
T74.31XD Adult psychological abuse by nonspouse or nonpartner, Confirmed,
Subsequent encounter
T74.31XD Spouse or partner abuse, Psycholo gical, Confirmed, Subsequent encounter
T74.32XA Child psychological abuse, Confirmed, Initial encounter
T74.32XD Child psychological abuse, Confirmed, Subsequent encounter
T76.01XA Spouse or partner neglec t, Suspected, Initial encounter
T76.01XD Spouse or partner neglect, Suspected, Subsequent encounter
T76.02XA Child neglect, Suspected, Initial encounter
T76.02XD Child neglect, Suspected, Subsequent encounter
T76.11XA Adult physical abuse by nonspouse or nonpartner, Suspected, Initial encounter
T76.11XA Spouse or partner violence, Ph ysical, Suspected, Initial encounter
T76.11XD Adult physical abus e by nonspouse or nonpartn er, Suspected, Subsequent
encounter
T76.11XD Spouse or partner violence, Phys ical, Suspected, Subsequent encounter
T76.12XA Child physical abuse, Suspected, Initial encounter
T76.12XD Child physical abuse, Suspected, Subsequent encounter | dsm5.pdf |
45e838104c6b-1 | T76.12XD Child physical abuse, Suspected, Subsequent encounter
T76.21XA Adult sexual abuse by nonspouse or nonpartner, Suspected, Initial encounter
T76.21XA Spouse or partner violence, Sexual, Suspected, Initial encounter
T76.21XD Adult sexual abuse by nonspouse or nonpartner, Suspected, Subsequent
encounter
T76.21XD Spouse or partner violence, Se xual, Suspected, Subsequent encounter
T76.22XA Child sexual abuse, Suspected, Initial encounter
T76.22XD Child sexual abuse, Su spected, Subsequent encounter
T76.31XA Adult psychological abuse by nonspouse or nonpartner, Suspected, Initial
encounter
T76.31XA Spouse or partner abuse, Psychological, Suspected, Initial encounter
T76.31XD Adult psychological abuse by nonspouse or nonpartner, Suspected,
Subsequent encounter
T76.31XD Spouse or partner abuse, Psychological, Suspected, Subsequent encounter
T76.32XA Child psychological abuse, Suspected, Initial encounter
T76.32XD Child psychological abuse, Suspected, Subsequent encounter
Z55.9 Academic or educational problem
Z56.82 Problem related to current military deployment status
Z56.9 Other problem related to employment
Z59.0 Homelessness
Z59.1 Inadequate housing
Z59.2 Discord with neighbor, lodger, or landlord
Z59.3 Problem related to living in a residential institution
Z59.4 Lack of adequate food or safe drinking water
Z59.5 Extreme povertyICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
62601fe857f9-0 | Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM) 895
Z59.6 Low income
Z59.7 Insufficient social insurance or welfare support
Z59.9 Unspecified housin g or economic problem
Z60.0 Phase of life problem
Z60.2 Problem related to living alone
Z60.3 Acculturation difficulty
Z60.4 Social exclusion or rejection
Z60.5 Target of (perceived) advers e discrimination or persecution
Z60.9 Unspecified problem related to social environment
Z62.29 Upbringing away from parents
Z62.810 Personal history (past histor y) of physical abuse in childhood
Z62.810 Personal history (past history) of sexual abuse in childhood
Z62.811 Personal history (past history) of psychological abuse in childhood
Z62.812 Personal history (past history) of neglect in childhood
Z62.820 Parent-child relational problem
Z62.891 Sibling relational problem
Z62.898 Child affected by pa rental relationship distress
Z63.0 Relationship distress with spouse or intimate partner
Z63.4 Uncomplicated bereavement
Z63.5 Disruption of family by separation or divorce
Z63.8 High expressed emotion level within family
Z64.0 Problems related to unwanted pregnancy
Z64.1 Problems related to multiparity
Z64.4 Discord with social service provider, including probation officer, case
manager, or social services worker
Z65.0 Conviction in civil or crimin al proceedings without imprisonment
Z65.1 Imprisonment or other incarceration
Z65.2 Problems related to release from prison
Z65.3 Problems related to ot her legal circumstances
Z65.4 Victim of crime
Z65.4 Victim of terrorism or torture
Z65.5 Exposure to disaster, war, or other hostilities | dsm5.pdf |
62601fe857f9-1 | Z65.5 Exposure to disaster, war, or other hostilities
Z65.8 Other problem related to psychosocial circumstances
Z65.8 Religious or spiritual problem
Z65.9 Unspecified problem related to unspecified psychosocial circumstances
Z69.010 Encounter for mental health services fo r victim of child abuse by parent
Z69.010 Encounter for mental health services for victim of child neglect by parent
Z69.010 Encounter for mental health services for victim of child psychological abuse by
parent
Z69.010 Encounter for mental he alth services for victim of child sexual abuse by parent
Z69.011 Encounter for mental health services fo r perpetrator of parental child abuse
Z69.011 Encounter for mental health services for perpetrator of parental child neglect
Z69.011 Encounter for mental health serv ices for perpetrator of parental child
psychological abuse
Z69.011 Encounter for mental heal th services for perpetrator of parental child sexual abuse
Z69.020 Encounter for mental health services fo r victim of nonparental child abuseICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
3b798e194b0b-0 | 896 Numerical Listing of DSM-5 Diagnoses and Codes (ICD-10-CM)
Z69.020 Encounter for mental health services fo r victim of nonparental child neglect
Z69.020 Encounter for mental health services fo r victim of nonparental child psycho-
logical abuse
Z69.020 Encounter for mental he alth services for victim of nonparental child sexual abuse
Z69.021 Encounter for mental he alth services for perpetrato r of nonparental child abuse
Z69.021 Encounter for mental he alth services for perpetrator of nonparental child neglect
Z69.021 Encounter for mental health services for perpetrator of nonparental child
psychological abuse
Z69.021 Encounter for mental health services for perpetrator of nonparental child
sexual abuse
Z69.11 Encounter for mental health services for victim of spouse or partner neglect
Z69.11 Encounter for mental health servic es for victim of spouse or partner
psychological abuse
Z69.11 Encounter for mental health services for victim of spouse or partner violence,
Physical
Z69.12 Encounter for mental heal th services for perpetrator of spouse or partner neglect
Z69.12 Encounter for mental health services for perpetrator of spouse or partner
psychological abuse
Z69.12 Encounter for mental health services for perpetrator of spouse or partner
violence, Physical
Z69.12 Encounter for mental health services for perpetrator of spouse or partner
violence, Sexual
Z69.81 Encounter for mental health services for victim of nonspousal adult abuse
Z69.81 Encounter for mental health services for victim of spouse or partner violence,
Sexual
Z69.82 Encounter for mental he alth services for perpetrator of nonspousal adult abuse
Z70.9 Sex counseling
Z71.9 Other counseling or consultation | dsm5.pdf |
3b798e194b0b-1 | Z70.9 Sex counseling
Z71.9 Other counseling or consultation
Z72.0 Tobacco us e disorder, mild
Z72.810 Child or adolesce nt antisocial behavior
Z72.811 Adult antisocial behavior
Z72.9 Problem related to lifestyle
Z75.3 Unavailability or inaccessibility of health care facilities
Z75.4 Unavailability or inaccessib ility of other helping agencies
Z76.5 Malingering
Z91.19 Nonadherence to medical treatment
Z91.410 Personal history (past history) of spouse or partne r violence, Physical
Z91.410 Personal history (past history) of spouse or partner violence, Sexual
Z91.411 Personal history (past history) of spouse or partner psychological abuse
Z91.412 Personal history (past histor y) of spouse or partner neglect
Z91.49 Other personal history of psychological trauma
Z91.5 Personal history of self-harm
Z91.82 Personal history of military deployment
Z91.83 Wandering associated with a mental disorder
Z91.89 Other personal risk factorsICD-10-CM Disorder, co ndition, or problem | dsm5.pdf |
89512ea02ed7-0 | 897DSM-5 Advisors and
Other Contributors
APA Board of Trustees DSM-5 Review Committees
Scientific Review Committee (SRC)
Kenneth S. Kendler, M.D. (Chair)
Robert Freedman, M.D. (Co-chair)
Dan G. Blazer, M.D., Ph.D., M.P.H.
David Brent, M.D. (2011–)
Ellen Leibenluft, M.D.
Sir Michael Rutter, M.D. (–2011)
Paul S. Summergrad, M.D.
Robert J. Ursano, M.D. (–2011)
Myrna Weissman , Ph.D. (2011–)
Joel Yager, M.D.
Jill L. Opalesky M.S. (Administrative Support)
Clinical and Public Health Review
Committee (CPHC)
John S. McIntyre, M.D. (Chair)
Joel Yager, M.D. (Co-chair)
Anita Everett M.D.
Cathryn A. Galanter, M.D.
Jeffrey M. Lyness, M.D.
James E. Nininger, M.D.
Victor I. Reus, M.D.
Michael J. Vergare, M.D.
Ann Miller (Administrative Support)
Oversight Committee
Carolyn Robinowitz, M.D. (Chair)
Mary Badaracco, M.D.
Ronald Burd, M.D.
Robert Freedman, M.D.
Jeffrey A. Lieberman, M.D.
Kyla Pope, M.D.
Victor I. Reus, M.D.
Daniel K. Winstead, M.D.
Joel Yager, M.D.
APA Assembly DSM-5 Review
Committee
Glenn A. Martin, M.D. (Chair) | dsm5.pdf |
89512ea02ed7-1 | Committee
Glenn A. Martin, M.D. (Chair)
R. Scott Benson, M.D. (Speaker of the
Assembly)
William Cardasis, M.D.
John M. de Figueiredo, M.D.
Lawrence S. Gross, M.D.
Brian S. Hart, M.D.Stephen A. McLeod Bryant, M.D.
Gregory A. Miller, M.D.
Roger Peele, M.D.
Charles S. Price, M.D.
Deepika Sastry, M.D.
John P.D. Shemo, M.D.
Eliot Sorel, M.D.
DSM-5 Summit Group
Dilip V. Jeste, M.D. (Chair)
R. Scott Benson, M.D.
Kenneth S. Kendler, M.D.
Helena C. Kraemer, Ph.D.
David J. Kupfer, M.D.
Jeffrey A. Lieberman, M.D.
Glenn A. Martin, M.D.
John S. McIntyre, M.D.
John M. Oldham, M.D.
Roger Peele, M.D.
Darrel A. Regier, M.D., M.P.H.
James H. Scully Jr., M.D.
Joel Yager, M.D.
Paul S. Appelbaum, M.D. (Consultant)
Michael B. First, M.D. (Consultant)
DSM-5 Field Trials Review
Robert D. Gibbons, Ph.D.
Craig Nelson, M.D.
DSM-5 Forensic Review
Paul S. Appelbaum, M.D.
Lama Bazzi, M.D.
Alec W. Buchanan, M.D., Ph.D.
Carissa Cabán Alemán, M.D. | dsm5.pdf |
89512ea02ed7-2 | Carissa Cabán Alemán, M.D.
Michael Champion, M.D.
Jeffrey C. Eisen, M.D.
Elizabeth Ford, M.D.
Daniel T. Hackman, M.D.
Mark Hauser, M.D.
Steven K. Hoge, M.D., M.B.A.
Debra A. Pinals, M.D.
Guillermo Portillo, M.D.
Patricia Recupero, M.D., J.D.
Robert Weinstock, M.D.
Cheryl Wills, M.D.
Howard V. Zonana, M.D. | dsm5.pdf |
21acfdac1bec-0 | 898 DSM-5 Advisors and Other Contributors
Past DSM-5 APA Staff
Erin J. Dalder-Alpher
Kristin Edwards
Leah I. EngelLenna Jawdat
Elizabeth C. Martin
Rocio J. Salvador
Work Group Advisors
ADHD and Disruptive Behavior
Disorders
Emil F. Coccaro, M.D.
Deborah Dabrick, Ph.D.
Prudence W. Fisher, Ph.D.
Benjamin B. Lahey, Ph.D.
Salvatore Mannuzza, Ph.D.
Mary Solanto, Ph.D.
J. Blake Turner, Ph.D.
Eric Youngstrom, Ph.D.
Anxiety, Obsessive-Compulsive
Spectrum, Posttraumatic, and
Dissociative Disorders
Lynn E. Alden, Ph.D.
David B. Arciniegas, M.D.
David H. Barlow, Ph.D.
Katja Beesdo-Baum, Ph.D.
Chris R. Brewin, Ph.D.
Richard J. Brown, Ph.D.
Timothy A. Brown, Ph.D.
Richard A. Bryant, Ph.D.
Joan M. Cook, Ph.D.
Joop de Jong, M.D., Ph.D.
Paul F. Dell, Ph.D.
Damiaan Denys, M.D.
Bruce P. Dohrenwend, Ph.D.
Brian A. Fallon, M.D., M.P.H.
Edna B. Foa, Ph.D.
Martin E. Franklin, Ph.D.
Wayne K. Goodman, M.D.
Jon E. Grant, J.D., M.D.
Bonnie L. Green, Ph.D.
Richard G. Heimberg, Ph.D.
Judith L. Herman, M.D. | dsm5.pdf |
21acfdac1bec-1 | Judith L. Herman, M.D.
Devon E. Hinton, M.D., Ph.D.
Stefan G. Hofmann, Ph.D.
Charles W. Hoge, M.D.
Terence M. Keane, Ph.D.
Nancy J. Keuthen, Ph.D.
Dean G. Kilpatrick, Ph.D.
Katharina Kircanski, Ph.D.
Laurence J. Kirmayer, M.D.
Donald F. Klein, M.D., D.Sc.
Amaro J. Laria, Ph.D.
Richard T. LeBeau, M.A.
Richard J. Loewenstein, M.D.
David Mataix-Cols, Ph.D.
Thomas W. McAllister, M.D.Harrison G. Pope, M.D., M.P.H.
Ronald M. Rapee, Ph.D.
Steven A. Rasmussen, M.D.
Patricia A. Resick, Ph.D.
Vedat Sar, M.D.
Sanjaya Saxena, M.D.
Paula P. Schnurr, Ph.D.
M. Katherine Shear, M.D.
Daphne Simeon, M.D.
Harvey S. Singer, M.D.
Melinda A. Stanley, Ph.D.
James J. Strain, M.D.
Kate Wolitzky Taylor, Ph.D.
Onno van der Hart, Ph.D.
Eric Vermetten, M.D., Ph.D.
John T. Walkup, M.D.
Sabine Wilhelm, Ph.D.
Douglas W. Woods, Ph.D.
Richard E. Zinbarg, Ph.D.
Joseph Zohar, M.D.
Childhood and Adolescent
Disorders
Adrian Angold, Ph.D. | dsm5.pdf |
21acfdac1bec-2 | Childhood and Adolescent
Disorders
Adrian Angold, Ph.D.
Deborah Beidel, Ph.D.
David Brent, M.D.
John Campo, M.D.
Gabrielle Carlson, M.D.
Prudence W. Fisher, Ph.D.
David Klonsky, Ph.D.
Matthew Nock, Ph.D.
J. Blake Turner, Ph.D.
Eating Disorders
Michael J. Devlin, M.D.
Denise E. Wilfley, Ph.D.
Susan Z. Yanovski, M.D.
Mood Disorders
Boris Birmaher, M.D.
Yeates Conwell, M.D.
Ellen B. Dennehy, Ph.D.
S. Ann Hartlage, Ph.D.
Jack M. Hettema, M.D., Ph.D.
Michael C. Neale, Ph.D.
Gordon B. Parker, M.D., Ph.D., D.Sc.
Roy H. Perlis, M.D. M.Sc.
Holly G. Prigerson, Ph.D.
Norman E. Rosenthal, M.D.
Peter J. Schmidt, M.D. | dsm5.pdf |
9c9f65d91410-0 | DSM-5 Advisors and Other Contributors 899
Mort M. Silverman, M.D.
Meir Steiner, M.D., Ph.D.
Mauricio Tohen, M.D., Dr.P.H., M.B.A.
Sidney Zisook, M.D.
Neurocognitive Disorders
Jiska Cohen-Mansfield, Ph.D.
Vladimir Hachinski, M.D., C.M., D.Sc.
Sharon Inouye, M.D., M.P.H.
Grant Iverson, Ph.D.
Laura Marsh, M.D.
Bruce Miller, M.D.
Jacobo Mintzer, M.D., M.B.A.
Bruce Pollock, M.D., Ph.D.
George Prigatano, Ph.D.
Ron Ruff, Ph.D.
Ingmar Skoog, M.D., Ph.D.
Robert Sweet, M.D.
Paula Trzepacz, M.D.
Neurodevelopmental Disorders
Ari Ne’eman
Nickola Nelson, Ph.D.
Diane Paul, Ph.D.
Eva Petrova, Ph.D.
Andrew Pickles, Ph.D.
Jan Piek, Ph.D.
Helene Polatajko, Ph.D.
Alya Reeve, M.D.
Mabel Rice, Ph.D.
Joseph Sergeant, Ph.D.
Bennett Shaywitz, M.D.
Sally Shaywitz, M.D.
Audrey Thurm, Ph.D.
Keith Widaman, Ph.D.
Warren Zigman, Ph.D.
Personality and Personality
Disorders
Eran Chemerinski, M.D.
Thomas N. Crawford, Ph.D.
Harold W. Koenigsberg, M.D.
Kristian E. Markon, Ph.D. | dsm5.pdf |
9c9f65d91410-1 | Kristian E. Markon, Ph.D.
Rebecca L. Shiner, Ph.D.
Kenneth R. Silk, M.D.
Jennifer L. Tackett, Ph.D.
David Watson, Ph.D.
Psychotic Disorders
Kamaldeep Bhui, M.D.
Manuel J. Cuesta, M.D., Ph.D.
Richard Douyon, M.D.
Paolo Fusar-Poli, Ph.D.
John H. Krystal, M.D.
Thomas H. McGlashan, M.D.
Victor Peralta, M.D., Ph.D.
Anita Riecher-Rössler, M.D.
Mary V. Seeman, M.D.Sexual and Gender Identity
Disorders
Stan E. Althof, Ph.D.
Richard Balon, M.D.
John H.J. Bancroft, M.D., M.A., D.P.M.
Howard E. Barbaree, Ph.D., M.A.
Rosemary J. Basson, M.D.
Sophie Bergeron, Ph.D.
Anita L. Clayton, M.D.
David L. Delmonico, Ph.D.
Domenico Di Ceglie, M.D.
Esther Gomez-Gil, M.D.
Jamison Green, Ph.D.
Richard Green, M.D, J.D.
R. Karl Hanson, Ph.D.
Lawrence Hartmann, M.D.
Stephen J. Hucker, M.B.
Eric S. Janus, J.D.
Patrick M. Jern, Ph.D.
Megan S. Kaplan, Ph.D.
Raymond A. Knight, Ph.D.
Ellen T.M. Laan, Ph.D.
Stephen B. Levine, M.D.
Christopher G. McMahon, M.B. | dsm5.pdf |
9c9f65d91410-2 | Stephen B. Levine, M.D.
Christopher G. McMahon, M.B.
Marta Meana, Ph.D.
Michael H. Miner, Ph.D., M.A.
William T. O’Donohue, Ph.D.
Michael A. Perelman, Ph.D.
Caroline F. Pukall, Ph.D.
Robert E. Pyke, M.D., Ph.D.
Vernon L. Quinsey, Ph.D. M.Sc.
David L. Rowland, Ph.D., M.A.
Michael Sand, Ph.D., M.P.H.
Leslie R. Schover, Ph.D., M.A.
Paul Stern, B.S, J.D.
David Thornton, Ph.D.
Leonore Tiefer, Ph.D.
Douglas E. Tucker, M.D.
Jacques van Lankveld, Ph.D.
Marcel D. Waldinger, M.D., Ph.D.
Sleep-Wake Disorders
Donald L. Bliwise, Ph.D.
Daniel J. Buysse, M.D.
Vishesh K. Kapur, M.D., M.P.H.
Sanjeeve V. Kothare, M.D.
Kenneth L. Lichstein, Ph.D.
Mark W. Mahowald, M.D.
Rachel Manber, Ph.D.
Emmanuel Mignot , M.D., Ph.D.
Timothy H. Monk, Ph.D., D.Sc.
Thomas C. Neylan, M.D.
Maurice M. Ohayon, M.D., D.Sc., Ph.D.
Judith Owens, M.D., M.P.H.
Daniel L. Picchietti, M.D.
Stuart F. Quan, M.D.
Thomas Roth, Ph.D.
Daniel Weintraub, M.D. | dsm5.pdf |
325e8074e601-0 | 900 DSM-5 Advisors and Other Contributors
Theresa B. Young, Ph.D.
Phyllis C. Zee, M.D., Ph.D.
Somatic Symptom Disorders
Brenda Bursch, Ph.D.
Kurt Kroenke, M.D.
W. Curt LaFrance, Jr., M.D., M.P.H.
Jon Stone, M.B., Ch.B., Ph.D.
Lynn M. Wegner, M.D.Substance-Related Disorders
Raymond F. Anton, Jr., M.D.
Deborah A. Dawson, Ph.D.
Roland R. Griffiths, Ph.D.
Dorothy K. Hatsukami, Ph.D.
John E. Helzer, M.D.
Marilyn A. Huestis, Ph.D.
John R. Hughes, M.D.
Laura M. Juliano, Ph.D.
Thomas R. Kosten, M.D.
Nora D. Volkow, M.D.
DSM-5 Study Group and Ot her DSM-5 Group Advisors
Lifespan Developmental
Approaches
Christina Bryant, Ph.D.
Amber Gum, Ph.D.
Thomas Meeks, M.D.
Jan Mohlman, Ph.D.
Steven Thorp, Ph.D.
Julie Wetherell, Ph.D.
Gender and Cross-Cultural Issues
Neil K. Aggarwal, M.D., M.B.A., M.A.
Sofie Bäärnhielm, M.D., Ph.D.
José J. Bauermeister, Ph.D.
James Boehnlein, M.D., M.Sc.
Jaswant Guzder, M.D.
Alejandro Interian, Ph.D.
Sushrut S. Jadhav, M.B.B.S., M.D., Ph.D. | dsm5.pdf |
325e8074e601-1 | Laurence J. Kirmayer, M.D.
Alex J. Kopelowicz, M.D.
Amaro J. Laria, Ph.D.
Steven R. Lopez, Ph.D.
Kwame J. McKenzie, M.D.
John R. Peteet, M.D.Hans (J.G.B.M.) Rohlof, M.D.
Cecile Rousseau, M.D.
Mitchell G. Weiss, M.D., Ph.D.
Psychiatric/General Medical
Interface
Daniel L. Coury, M.D.
Bernard P. Dreyer, M.D.
Danielle Laraque, M.D.
Lynn M. Wegner, M.D.
Impairment and Disability
Prudence W. Fisher, Ph.D.
Martin Prince, M.D., M.Sc.
Michael R. Von Korff, Sc.D.
Diagnostic Assessment
Instruments
Prudence W. Fisher, Ph.D.
Robert D. Gibbons, Ph.D.
Ruben Gur, Ph.D.
John E. Helzer, M.D.
John Houston, M.D., Ph.D.
Kurt Kroenke, M.D.
Other Contributo rs/Consultants
ADHD and Disruptive Behavior
Disorders
Patrick E. Shrout, Ph.D.
Erik Willcutt, Ph.D.
Anxiety, Obsessive-Compulsive
Spectrum, Posttraumatic, and
Dissociative Disorders
Etzel Cardeña, Ph.D.
Richard J. Castillo, Ph.D.
Eric Hollander, M.D.
Charlie Marmar, M.D.
Alfonso Martínez-Taboas, Ph.D.
Mark W. Miller, Ph.D.
Mark H. Pollack, M.D. | dsm5.pdf |
325e8074e601-2 | Mark W. Miller, Ph.D.
Mark H. Pollack, M.D.
Heidi S. Resnick, Ph.D.Childhood and Adolescent
Disorders
Grace T. Baranek, Ph.D.
Colleen Jacobson, Ph.D.
Maria Oquendo, M.D.
Sir Michael Rutter, M.D.
Eating Disorders
Nancy L. Zucker, Ph.D.
Mood Disorders
Keith Hawton, M.D., Ph.D.
David A. Jobes, Ph.D.
Maria A. Oquendo, M.D.
Alan C. Swann, M.D. | dsm5.pdf |
7d95399f4570-0 | DSM-5 Advisors and Other Contributors 901
Neurocognitive Disorders
J. Eric Ahlskog, M.D., Ph.D.
Allen J. Aksamit, M.D.
Marilyn Albert, Ph.D.
Guy Mckhann, M.D.
Bradley Boeve, M.D.
Helena Chui, M.D.
Sureyya Dikmen, Ph.D.
Douglas Galasko, M.D.
Harvey Levin, Ph.D.
Mark Lovell, Ph.D.
Jeffery Max, M.B.B.Ch.
Ian McKeith, M.D.
Cynthia Munro, Ph.D.
Marlene Oscar-Berman, Ph.D.
Alexander Troster, Ph.D.
Neurodevelopmental Disorders
Anna Barnett, Ph.D.
Martha Denckla, M.D.
Jack M. Fletcher, Ph.D.
Dido Green, Ph.D.
Stephen Greenspan, Ph.D.
Bruce Pennington, Ph.D.
Ruth Shalev, M.D.
Larry B. Silver, M.D.
Lauren Swineford, Ph.D.
Michael Von Aster, M.D.
Personality and Personality
Disorders
Patricia R. Cohen, Ph.D.
Jaime L. Derringer, Ph.D.
Lauren Helm, M.D.
Christopher J. Patrick, Ph.D.
Anthony Pinto, Ph.D.
Psychotic Disorders
Scott W. Woods, M.D.
Sexual and Gender Identity
Disorders
Alan J. Riley, M.Sc.
Ray C. Rosen, Ph.D.
Sleep-Wake Disorders
Jack D. Edinger, Ph.D.
David Gozal, M.D. | dsm5.pdf |
7d95399f4570-1 | David Gozal, M.D.
Hochang B. Lee, M.D.
Tore A. Nielsen, Ph.D.
Michael J. Sateia, M.D.
Jamie M. Zeitzer, Ph.D.
Somatic Symptom Disorders
Chuck V. Ford, M.D.
Patricia I. Rosebush, M.Sc.N., M.D. Substance-Related Disorders
Sally M. Anderson, Ph.D.
Julie A. Kable, Ph.D.
Christopher Martin, Ph.D.
Sarah N. Mattson, Ph.D.
Edward V. Nunes, Jr., M.D.
Mary J. O’Connor, Ph.D.
Heather Carmichael Olson, Ph.D.
Blair Paley, Ph.D.
Edward P. Riley, Ph.D.
Tulshi D. Saha, Ph.D.
Wim van den Brink, M.D., Ph.D.
George E. Woody, M.D.
Diagnostic Spectra and DSM/ICD
Harmonization
Bruce Cuthbert, Ph.D.
Lifespan Developmental
Approaches
Aartjan Beekman Ph.D.
Alistair Flint, M.B.
David Sultzer, M.D.
Ellen Whyte, M.D.
Gender and Cross-Cultural Issues
Sergio Aguilar-Gaxiola, M.D., Ph.D.
Kavoos G. Bassiri, M.S.
Venkataramana Bhat, M.D.
Marit Boiler, M.P.H.
Denise Canso, M.Sc.
Smita N. Deshpande, M.D., D.P.M.
Ravi DeSilva, M.D. | dsm5.pdf |
7d95399f4570-2 | Ravi DeSilva, M.D.
Esperanza Diaz, M.D.
Byron J. Good, Ph.D.
Simon Groen, M.A.
Ladson Hinton, M.D.
Lincoln I. Khasakhala, Ph.D.
Francis G. Lu, M.D.
Athena Madan, M.A.
Anne W. Mbwayo, Ph.D.
Oanh Meyer, Ph.D.
Victoria N. Mutiso, Ph.D., D.Sc.
David M. Ndetei, M.D.
Andel V. Nicasio, M.S.Ed.
Vasudeo Paralikar, M.D., Ph.D.
Kanak Patil, M.A.
Filipa I. Santos, H.B.Sc.
Sanjeev B. Sarmukaddam, Ph.D., M.Sc.
Monica Z. Scal co, M.D., Ph.D.
Katie Thompson, M.A.
Hendry Ton, M.D., M.Sc.
Rob C.J. van Dijk, M.Sc.
William A. Vega, Ph.D.
Johann M. Vega-Dienstmaier, M.D.
Joseph Westermeyer, M.D., Ph.D. | dsm5.pdf |
b6e6978bd802-0 | 902 DSM-5 Advisors and Other Contributors
Psychiatric/General Medical
Interface
Daniel J. Balog, M.D.
Charles C. Engel, M.D., M.P.H.
Charles D. Motsinger, M.D.
Impairment and Disability
Cille Kennedy, Ph.D.
Diagnostic Assessment
Instruments
Paul J. Pikonis, Ph.D. Other Conditions That May Be
a Focus of Clinical Attention
William E. Narrow, M.D., M.P.H., Chair
Roger Peele, M.D.
Lawson R. Wulsin, M.D.
Charles H. Zeanah, M.D.
Prudence W. Fisher, Ph.D., Advisor
Stanley N. Caroff, M.D., Contributor/Consultant
James B. Lohr, M.D., Contributor/Consultant
Marianne Wambolt, Ph.D., Contributor/Consultant
DSM-5 Research Group
Allan Donner, Ph.D.
CPHC Peer Reviewers
Kenneth Altshuler, M.D.
Pedro G. Alvarenga, M.D.
Diana J. Antonacci, M.D.
Richard Balon, M.D.
David H. Barlow, Ph.D.
L. Jarrett Ba rnhill, M.D.
Katja Beesdo-Baum, Ph.D.
Marty Boman, Ed.D.
James Bourgeois, M.D.
David Braff, M.D.
Harry Brandt, M.D.
Kirk Brower, M.D.
Rachel Bryant-Waugh, Ph.D.
Jack D. Burke Jr., M.D., M.P.H.
Brenda Bursch, Ph.D.
Joseph Camilleri, M.D.
Patricia Casey, M.D. | dsm5.pdf |
b6e6978bd802-1 | Joseph Camilleri, M.D.
Patricia Casey, M.D.
F. Xavier Castellanos, M.D.
Eran Chemerinski, M.D.
Wai Chen, M.D.
Elie Cheniaux, M.D., D.Sc.
Cheryl Chessick, M.D,
J. Richard Ciccone, M.D.
Anita H. Clayton, M.D.
Tihalia J. Coleman, Ph.D.
John Csernansky, M.D.
Manuel J. Cuesta M.D., Ph.D.
Joanne L. Davis, M.D.
David L. Delmonico, Ph.D.
Ray J. DePaulo, M.D.
Dimitris Dikeos, M.D.
Ina E. Djonlagic, M.D.
C. Neill Epperson, M.D.
Javier I. Escobar, M.D., M.Sc.
Spencer Eth, M.D.
David Fassler, M.D.
Giovanni A. Fava, M.D.
Robert Feinstein, M.D.
Molly Finnerty, M.D.
Mark H. Fleisher, M.D.
Alessio Florentini, M.D.Laura Fochtmann, M.D.
Marshal Forstein, M.D.
William French, M.D.
Maximillian Gahr, M.D.
Cynthia Geppert, M.D.
Ann Germaine, Ph.D.
Marcia Goin, M.D.
David A. Gorelick, M.D., Ph.D.
David Graeber, M.D.
Cynthia A. Graham, Ph.D.
Andreas Hartmann, M.D.
Victoria Hendrick, M.D.
Merrill Herman, M.D.
David Herzog, M.D. | dsm5.pdf |
b6e6978bd802-2 | Merrill Herman, M.D.
David Herzog, M.D.
Mardi Horowitz, M.D.
Ya-fen Huang, M.D.
Anthony Kales, M.D
Niranjan S. Karnik, M.D., Ph.D.
Jeffrey Katzman, M.D.
Bryan King, M.D.
Cecilia Kjellgren, M.D.
Harold W. Koenigsberg, M.D.
Richard B. Krueger, M.D.
Steven Lamberti, M.D.
Ruth A. Lanius, M.D.
John Lauriello, M.D.
Anthony Lehman, M.D.
Michael Linden, M.D.
Mark W. Mahowald, M.D.
Marsha D. Marcus, Ph.D.
Stephen Marder, M.D.
Wendy Marsh, M.D.
Michael S. McCloskey, Ph.D.
Jeffrey Metzner, M.D.
Robert Michels, M.D.
Laura Miller, M.D.
Michael C. Miller, M.D.
Frederick Moeller, M.D.
Peter T. Morgan, M.D., Ph.D.
Madhav Muppa, M.D.
Philip Muskin, M.D. | dsm5.pdf |
1721bdbb1057-0 | DSM-5 Advisors and Other Contributors 903
Joachim Nitschke, M.D.
Abraham Nussbaum, M.D.
Ann Olincy, M.D.
Mark Onslow, Ph.D.
Sally Ozonoff, Ph.D.
John R. Peteet, M.D.
Ismene L. Petrakis, M.D.
Christophe M. Pfeiffer, M.D.
Karen Pierce, M.D.
Belinda Plattner, M.D.
Franklin Putnam, M.D.
Stuart F. Quan, M.D.
John Racy, M.D.
Phillip Resnick, M.D.
Michele Riba, M.D.
Jerold Rosenbaum, M.D.
Stephen Ross, M.D.
Lawrence Scahill, M.S.N., Ph.D.
Daniel Schechter, M.D.
Mary V. Seeman, M.D.
Alessandro Serretti, M.D.
Jianhua Shen, M.D.Ravi Kumar R. Singareddy, M.D.
Ingmar Skoog, M.D., Ph.D.
Gary Small, M.D.
Paul Soloff, M.D.
Christina Stadle r, M.D., Ph.D.
Nada Stotland, M.D.
Neil Swerdlow, M.D.
Kim Tillery, Ph.D.
David Tolin, Ph.D.
Jayne Trachman, M.D.
Luke Tsai, M.D.
Ming T. Tsuang, M.D., Ph.D.
Richard Tuch, M.D.
Johan Verhulst, M.D.
B. Timothy Walsh, M.D.
Michael Weissberg, M.D.
Godehard Weniger, M.D.
Keith Widaman, Ph.D. | dsm5.pdf |
1721bdbb1057-1 | Godehard Weniger, M.D.
Keith Widaman, Ph.D.
Thomas Wise, M.D.
George E. Woods, M.D.
Kimberly A. Yonkers, M.D.
Alexander Young, M.D.
DSM-5 Field Trials in Academic Clinical Centers—
Adult Samples
David Geffen School of Medicine, Univ ersity of California, Los Angeles
Investigator
Helen Lavretsky, M.D., Principal Investigator
Referring and Interviewing
Clinicians
Jessica Brommelhoff, Ph.D.
Xavier Cagigas, Ph.D.
Paul Cernin, Ph.D.
Linda Ercoli, Ph.D.
Randall Espinoza, M.D.Helen Lavretsky, M.D.
Jeanne Kim, Ph.D.
David Merrill, M.D.
Karen Miller, Ph.D.
Christopher Nunez, Ph.D.
Research Coordinators
Natalie St. Cyr, M.A., Lead Research
Coordinator
Nora Nazarian, B.A.
Colin Shinn, M.A.
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Investigators
Bruce G. Pollock, M.D., Ph.D., Lead Principal
Investigator
R. Michael Bagby, Ph.D., Principal Investigator
Kwame J. McKenzie, M.D., Principal
Investigator
Tony P. George, M.D., Co-investigator
Lena C. Quilty, Ph.D., Co-investigator
Peter Voore, M.D., Co-investigator
Referring and Interviewing Clinicians
Donna E. Akman, Ph.D.
R. Michael Bagby, Ph.D.
Wayne C. V. Baici, M.D. | dsm5.pdf |
1721bdbb1057-2 | Wayne C. V. Baici, M.D.
Crystal Baluyut, M.D.Eva W. C. Chow, M.D., J.D., M.P.H.
Z. J. Daskalakis, M.D., Ph.D.
Pablo Diaz-Hermosillo, M.D.
George Foussias, M.Sc., M.D.
Paul A. Frewen, Ph.D.
Ariel Graff-Guerrero, M.D., M.Sc., Ph.D.
Margaret K. Hahn, M.D.
Lorena Hsu, Ph.D.
Justine Joseph, Ph.D.
Sean Kidd, Ph.D.
Kwame J. McKenzie, M.D.
Mahesh Menon, Ph.D.
Romina Mizrahi, M.D., Ph.D.
Daniel J. Mueller, M.D., Ph.D.
Lena C. Quilty, Ph.D.
Anthony C. Ruocco, Ph.D. | dsm5.pdf |
8974fae8f0be-0 | 904 DSM-5 Advisors and Other Contributors
Jorge Soni, M.D.
Aristotle N. Voineskos, M.D., Ph.D.
George Voineskos, M.D.
Peter Voore, Ph.D.
Chris Watson, Ph.D.
Referring Clinicians
Ofer Agid, M.D.
Ash Bender, M.D.
Patricia Cavanagh, M.D.
Sarah Colman, M.D.
Vincenzo Deluca, M.D.
Justin Geagea, M.D.
David S. Goldbloom, M.D.
Daniel Greben, M.D.
Malati Gupta, M.D.
Ken Harrison, M.D.
Imraan Jeeva, M.D.
Joel Jeffries, M.B.
Judith Laposa, Ph.D.Jan Malat, M.D.
Shelley McMain, Ph.D.
Bruce Pollock, M.D., Ph.D.
Andriy V. Samokhva lov, M.D., Ph.D.
Martin Strassnig, M.D.
Albert H. C. Wong, M.D., Ph.D.
Research Coordinators
Gloria I. Leo, M.A., Lead Research Coordinator
Anissa D. Bachan, B.A.
Bahar Haji-Khamneh, M.A.
Olga Likhodi, M.Sc.
Eleanor J. Liu, Ph.D.
Sarah A. McGee Ng, B.B.A.
Other Research Staff
Susan E. Dickens, M.A., Clinical Research
Manager
Sandy Richards, B.Sc.N., Schizophrenia
Research Manager
Dallas VA Medical Center, Dallas, Texas
Investigators
Carol S. North, M.D., M.P.E., Principal
Investigator | dsm5.pdf |
8974fae8f0be-1 | Investigators
Carol S. North, M.D., M.P.E., Principal
Investigator
Alina Suris, Ph.D., A.B.P.P., Principal
Investigator
Referring and Interviewing Clinicians
Barry Ardolf, Psy.D.
Abila Awan, M.D.
Joel Baskin, M.D.
John Black, Ph.D.
Jeffrey Dodds, Ph.D.
Gloria Emmett, Ph.D.
Karma Hudson, M.D.
Jamylah Jackson, Ph.D., A.B.P.P.
Lynda Kirkland-Culp, Ph.D., A.B.P.P.
Heidi Koehler, Ph.D., A.B.P.P.
Elizabeth Lewis, Psy.D.
Aashish Parikh, M.D.
Reed Robinson, Ph.D.
Jheel Shah, M.D.
Geetha Shivakumar, M.D.
Sarah Spain, Ph.D., A.B.P.P.Lisa Thoman, Ph.D.
Lia Thomas, M.D.
Jamie Zabukovec, Psy.D.
Mustafa Zaidi, M.D.
Andrea Zartman, Ph.D.
General Referral Sources
Robert Blake, L.M.S.W.
Evelyn Gibbs, L.M.S.W.
Michelle King-Thompson, L.M.S.W.
Research Coordinators
Jeannie B. Whitman, Ph.D., Lead Research
Coordinator
Sunday Adewuyi, M.D.
Elizabeth Anderson, B.A.
Solaleh Azimipour, B.S.
Carissa Barney, B.S.
Kristie Cavazos, B.A.
Robert Devereaux, B.S.
Dana Downs, M.S., M.S.W.
Sharjeel Farooqui, M.D.
Julia Smith, Psy.D. | dsm5.pdf |
8974fae8f0be-2 | Sharjeel Farooqui, M.D.
Julia Smith, Psy.D.
Kun-Ying H. Sung, B.S.
School of Medicine, The University of Texas San Antonio,
San Antonio, Texas
Investigator
Mauricio Tohen, M.D., Dr.P.H., M.B.A.,
Principal Investigator
Referring and Interviewing Clinicians
Suman Baddam, Psy.D.
Charles L. Bowden, M.D.Nancy Diazgranados, M.D., M.S.
Craig A. Dike, Psy.D.
Dianne E. Dunn, Psy.D., M.P.H.
Elena Gherman, M.D.
Jodi M. Gonzalez, Ph.D.
Pablo Gonzalez, M.D.
Phillip Lai, Psy.D. | dsm5.pdf |
186d77032008-0 | DSM-5 Advisors and Other Contributors 905
Natalie Maples-Aguilar, M.A., L.P.A.
Marlon P. Quinones, M.D.
Jeslina J. Raj, Psy.D.
David L. Roberts, Ph.D.
Nancy Sandusky, R.N., F.P.M.H.N.P.-B.C.,
D.N.P.-C.
Donna S. Stutes, M.S., L.P.C.
Mauricio Tohen, M.D., Dr.PH, M.B.A.
Dawn I. Velligan, Ph.D.
Weiran Wu, M.D., Ph.D.
Referring Clinicians
Albana Dassori, M.D.
Megan Frederick, M.A.Robert Gonzalez, M.D.
Uma Kasinath, M.D.
Camis Milam, M.D.
Vivek Singh, M.D.
Peter Thompson, M.D.
Research Coordinators
Melissa Hernandez, B.A., Lead Research
Coordinator
Fermin Alejandro Carrizales, B.A.
Martha Dahl, R.N., B.S.N.
Patrick M. Smith, B.A.
Nicole B. Watson, M.A.
Michael E. DeBakey VA Medical Center and the Menninger Clinic,
Houston, Texas (Joint Study Site)
Michael E. DeBakey VA Medical Center
Investigator
Laura Marsh, M.D., Principal Investigator
Referring and Interviewing Clinicians
Shalini Aggarwal, M.D.
Su Bailey, Ph.D.
Minnete (Helen) Beckner, Ph.D.
Crystal Clark, M.D.
Charles DeJohn, M.D.
Robert Garza, M.D.
Aruna Gottumakkla, M.D. | dsm5.pdf |
186d77032008-1 | Robert Garza, M.D.
Aruna Gottumakkla, M.D.
Janet Hickey, M.D.
James Ireland, M.D.
Mary Lois Lacey, A.P.R.N.
Wendy Leopoulos, M.D.
Laura Marsh, M.D.
Deleene Menefee, Ph.D.
Brian I. Miller, Ph.D.
Candy Smith, Ph.D.
Avila Steele, Ph.D.
Jill Wanner, Ph.D.
Rachel Wells, Ph.D.
Kaki York-Ward, Ph.D.Referring Clinicians
Sara Allison, M.D.
Leonard Denney, L.C.S.W.
Catherine Flores, L.C.S.W.
Nathalie Marie, M.D.
Christopher Martin, M.D.
Sanjay Mathew, M.D.
Erica Montgomery, M.D.
Gregory Scholl, P.A.
Jocelyn Ulanday, M.D., M.P.H.
Research Coordinators
Sarah Neely Torres, B.S., Lead Research
Coordinator
Kathleen Grout, M.A.
Lea Kiefer, M.P.H.
Jana Tran, M.A.
Volunteer Research Assistants
Catherine Clark
Linh Hoang
Menninger Clinic
Investigator
Efrain Bleiberg, M.D., Principal Investigator
Referring and Interviewing Clinicians
Jennifer Baumgardner, Ph.D.
Elizabeth Dodd Conaway, L.C.S.W., B.C.D.
Warren Christianson, D.O.
Wesley Clayton, L.M.S.W.
J. Christopher Fowler, Ph.D.
Michael Groat, Ph.D.
Edythe Harvey, M.D.
Denise Kagan, Ph.D. | dsm5.pdf |
186d77032008-2 | Edythe Harvey, M.D.
Denise Kagan, Ph.D.
Hans Meyer, L.C.S.W. Segundo Robert-Ibarra, M.D.
Sandhya Trivedi, M.D.
Rebecca Wagner, Ph.D.
Harrell Woodson, Ph.D.
Amanda Yoder, L.C.S.W.
Referring Clinicians
James Flack, M.D.
David Ness, M.D.
Research Coordinators
Steve Herrera, B.S., M.T., Lead Research
Coordinator
Allison Kalpakci, B.A. | dsm5.pdf |
6c80ab1389a6-0 | 906 DSM-5 Advisors and Other Contributors
Mayo Clinic, Rochester, Minnesota
Investigators
Mark A. Frye, M.D., Principal Investigator
Glenn E. Smith, Ph.D., Principal Investigator
Jeffrey P. Staab M.D., M.S., Principal
Investigator
Referring and Interviewing Clinicians
Osama Abulseoud, M.D.
Jane Cerhan, Ph.D.
Julie Fields, Ph.D.
Mark A. Frye, M.D.
Manuel Fuentes, M.D.
Yonas Geda, M.D.
Maria Harmandayan, M.D.
Reba King, M.D.
Simon Kung, M.D.
Mary Machuda, Ph.D.
Donald McAlpine, M.D.
Alastair McKean, M.D.
Juliana Moraes, M.D.
Teresa Rummans, M.D.James R. Rundell, M.D.
Richard Seime, Ph.D.
Glenn E. Smith, Ph.D.
Christopher Sola, D.O.
Jeffrey P. Staab M.D., M.S.
Marin Veldic, M.D.
Mark D. Williams, M.D.
Maya Yustis, Ph.D.
Research Coordinators
Lisa Seymour, B.S., Lead Research Coordinator
Scott Feeder, M.S.
Lee Gunderson, B.S.
Sherrie Hanna, M.A., L.P.
Kelly Harper, B.A.
Katie Mingo, B.A.
Cynthia Stoppel, A.S.
Other Study Staff
Anna Frye
Andrea Hogan
Perelman School of Medicine, University of Pennsylvania,
Philadelphia, Pennsylvania
Investigators
Mahendra T. Bhati, M.D., Principal Investigator | dsm5.pdf |
6c80ab1389a6-1 | Investigators
Mahendra T. Bhati, M.D., Principal Investigator
Marna S. Barrett, Ph.D., Co-investigator
Michael E. Thase, M. D., Co-investigator
Referring and Interviewing Clinicians
Peter B. Bloom, M.D.
Nicole K Chalmers L.C.S.W.
Torrey A. Creed, Ph.D.
Mario Cristancho, M.D.
Amy Cunningham, Psy.D.
John P. Dennis, Ph.D.
Josephine Elia, M.D.
Peter Gariti, Ph.D., L.C.S.W.
Philip Gehrman, Ph.D.
Laurie Gray, M.D.
Emily A.P. Haigh, Ph.D.
Nora J. Johnson, M.B.A., M.S., Psy.D.
Paulo Knapp, M.D.
Yong-Tong Li, M.D.
Bill Mace, Ph.D.
Kevin S. McCarthy, Ph.D.
Dimitri Perivoliotis, Ph.D.
Luke Schultz, Ph.D.
Tracy Steen, Ph.D.
Chris Tjoa, M.D.
Nancy A. Wintering, L.C.S.W.
Referring Clinicians
Eleanor Ainslie, M.D.
Kelly C. Allison, Ph.D.Rebecca Aspden, M.D.
Claudia F. Baldassano, M.D.
Vijayta Bansal, M.D.
Rachel A. Bennett, M.D.
Richard Bollinger, Ph.D.
Andrea Bowen, M.D.
Karla Campanella, M.D.
Anthony Carlino, M.D.
Noah Carroll, M.S.S.
Alysia Cirona, M.D.
Samuel Collier, M.D. | dsm5.pdf |
6c80ab1389a6-2 | Alysia Cirona, M.D.
Samuel Collier, M.D.
Andreea Crauciuc, L.C.S.W.
Pilar Cristancho, M.D.
Traci D'Almeida, M.D.
Kathleen Diller, M.D.
Benoit Dubé, M.D.
Jon Dukes, M.S.W.
Lauren Elliott, M.D.
Mira Elwell, B.A.
Mia Everett, M.D.
Lucy F. Faulconbridge, Ph.D.
Patricia Furlan, Ph.D.
Joanna Goldstein, L.C.S.W.
Paul Grant, Ph.D.
Jillian Graves, L.C.S.W.
Tamar Gur, M.D., Ph.D.
Alisa Gutman, M.D., Ph.D.
Nora Hymowitz, M.D.
Sofia Jensen, M.D.
Tiffany King, M.S.W.
Katherine Levine, M.D. | dsm5.pdf |
bfae9e0e5f3f-0 | DSM-5 Advisors and Other Contributors 907
Alice Li, M.D.
Janet Light, L.C.S.W.
John Listerud, M.D., Ph.D.
Emily Malcoun, Ph.D.
Donovan Maust, M.D.
Adam Meadows, M.D.
Michelle Moyer, M.D.
Rebecca Naugle, L.C.S.W.
Cory Newman, Ph.D.
John Northrop, M.D., Ph.D.
Elizabeth A. Ellis Ohr, Psy.D.
John O'Reardon, M.D.
Abraham Pachikara, M.D.
Andrea Perelman, M.S.W.
Diana Perez, M.S.W.
Bianca Previdi, M.D.
J. Russell Ramsay, Ph.D.
Jorge Rivera-Colon, M.D.
Jan Smedley, L.C.S.W.
Katie Struble, M.S.W.
Aita Susi, M.D.
Yekaterina Tatarchuk, M.D.
Ellen Tarves, M.A.
Allison Tweedie, M.D.
Holly Valerio, M.D.Thomas A. Wadden, Ph.D.
Joseph Wright, Ph.D.
Yan Xuan, M.D.
David Yusko, Psy.D.
Research Coordinators
Jordan A. Coello, B.A., Lead Research
Coordinator
Eric Wang, B.S.E.
Volunteer Research Assistants/
Interns
Jeannine Barker, M.A., A.T.R.
Jacqueline Baron
Kelsey Bogue
Alexandra Ciomek
Martekuor Dodoo, B.A.
Julian Domanico
Laura Heller, B.A.
Leah Hull-Rawson, B.A. | dsm5.pdf |
bfae9e0e5f3f-1 | Laura Heller, B.A.
Leah Hull-Rawson, B.A.
Jacquelyn Klehm, B.A.
Christina Lam
Dante Proetto, B.S.
Molly Roy
Casey Shannon
Stanford University School of Medicine, Stanford, California
Investigators
Carl Feinstein, M.D., Principal Investigator
Debra Safer, M.D., Principal Investigator
Referring and Interviewing Clinicians
Kari Berquist, Ph.D.
Eric Clausell, Ph.D.
Danielle Colborn, Ph.D.
Whitney Daniels, M.D.
Alison Darcy, Ph.D.
Krista Fielding, M.D.
Mina Fisher, M.D.
Kara Fitzpatrick, Ph.D.
Wendy Froehlich, M.D.
Grace Gengoux, Ph.D.
Anna Cassandra Golding, Ph.D.
Lisa Groesz, Ph.D.
Kyle Hinman, M.D.
Rob Holaway, Ph.D.
Matthew Holve, M.D.
Rex Huang, M.D.
Nina Kirz, M.D.
Megan Klabunde, Ph.D.
John Leckie, Ph.D.
Naomi Leslie, M.D.
Adrianne Lona, M.D.
Ranvinder Rai, M.D.
Rebecca Rialon, Ph.D.
Beverly Rodriguez, M.D., Ph.D.
Debra Safer, M.D.
Mary Sanders, Ph.D.Jamie Scaletta, Ph.D.
Norah Simpson, Ph.D.
Manpreet Singh, M.D.
Maria-Christina Stewart, Ph.D.
Melissa Vallas, M.D.
Patrick Whalen, Ph.D.
Sanno Zack, Ph.D.
Referring Clinicians | dsm5.pdf |
bfae9e0e5f3f-2 | Sanno Zack, Ph.D.
Referring Clinicians
Robin Apple, Ph.D.
Victor Carrion, M.D.
Carl Feinstein, M.D.
Christine Gray, Ph.D.
Antonio Hardan, M.D.
Megan Jones, Psy.D.
Linda Lotspeich, M.D.
Lauren Mikula, Psy.D.
Brandyn Street, Ph.D.
Violeta Tan, M.D.
Heather Taylor, Ph.D.
Jacob Towery, M.D.
Sharon Williams, Ph.D.
Research Coordinators
Kate Arnow, B.A., Lead Research Coordinator
Nandini Datta, B.S.
Stephanie Manasse, B.A.
Volunteer Research Assistants/
Interns
Arianna Martin, M.S.
Adriana Nevado, B.A. | dsm5.pdf |
33b432e54e72-0 | 908 DSM-5 Advisors and Other Contributors
Children’s Hospital Colorado, Aurora, Colorado
Investigator
Marianne Wamboldt , M.D., Principal
Investigator
Referring and Interviewing
Clinicians
Galia Abadi, M.D.
Steven Behling, Ph.D.
Jamie Blume, Ph.D.
Adam Burstein, M.D.
Debbie Carter, M.D.
Kelly Caywood, Ph.D.
Meredith Chapman, M.D.
Paulette Christian, A.P.P.M.H.N.
Mary Cook, M.D.
Anthony Cordaro, M.D.
Audrey Dumas, M.D.
Guido Frank, M.D.
Karen Frankel, Ph.D.
Darryl Graham, Ph.D.
Yael Granader, Ph.D.
Isabelle Guillemet, M.D.
Patrece Hairston, Ph.D.
Charles Harrison, Ph.D.
Tammy Herckner, L.C.S.W.
Cassie Karlsson, M.D.
Kimberly Kelsay, M.D.
David Kieval, Ph.D.
Megan Klabunde, Ph.D.
Jaimelyn Kost, L.C.S.W.
Harrison Levine, M.D.
Raven Lipmanson, M.D.
Susan Lurie, M.D.
Asa Marokus, M.D.
Idalia Massa, Ph.D.
Christine McDunn, Ph.D.
Scot McKay, M.D.
Marissa Murgolo, L.C.S.W.
Alyssa Oland, Ph.D.
Lina Patel, Ph.D.
Rheena Pineda, Ph.D.
Gautam Rajendran, M.D.
Diane Reichmuth, Ph.D | dsm5.pdf |
33b432e54e72-1 | Gautam Rajendran, M.D.
Diane Reichmuth, Ph.D
Michael Rollin, M.D.Marlena Romero, L.C.S.W.
Michelle Roy, Ph.D.
Celeste St. John-Larkin, M.D.
Elise Sannar, Ph.D.
Daniel Savin, M.D.
Claire Dean Sinclair, Ph.D.
Ashley Smith, L.C.S.W.
Mindy Solomon, Ph.D.
Sally Tarbell, Ph.D.
Helen Thilly, L.C.S.W.
Sara Tlustos-Carter, Ph.D.
Holly Vause, A.P.P.M.H.N
Marianne Wamboldt, M.D.
Angela Ward, L.C.S.W.
Jason Williams, Ph.D.
Jason Willoughby, Ph.D.
Brennan Young, Ph.D.
Referring Clinicians
Kelly Bhatnagar, Ph.D.
Jeffery Dolgan, Ph.D.
Jennifer Eichberg, L.C.S.W.
Jennifer Hagman, M.D.
James Masterson, L.C.S.W.
Hy Gia Park, M.D.
Tami Roblek, Ph.D.
Wendy Smith, Ph.D.
David Williams, M.D.
Research Coordinators
Laurie Burnside, M.S.M., C.C.R.C., Lead
Research Coordinator
Darci Anderson, B.A., C.C.R.C.
Heather Kennedy, M.P.H.
Amanda Millar, B.A.
Vanessa Waruinge, B.S.
Elizabeth Wallace, B.A.
Volunteer Research Assistants/
Interns
Wisdom Amouzou
Ashley Anderson
Michael Richards
Mateya Whyte
Baystate Medical Center, Springfield, Massachusetts
Investigators | dsm5.pdf |
33b432e54e72-2 | Michael Richards
Mateya Whyte
Baystate Medical Center, Springfield, Massachusetts
Investigators
Bruce Waslick, M.D., Principal Investigator
Cheryl Bonica, Ph.D., Co-investigator
John Fanton, M.D., Co-investigator
Barry Sarvet, M.D. , Co-investigator Referring and Interviewing Clinicians
Julie Bermant, R.N., M.S.N., N.P.
Cheryl Bonica, Ph.D.
Jodi Devine, L.I.C.S.W.
William Fahey, Ph.D.
John Fanton, M.D. | dsm5.pdf |
7d2f8f2a368f-0 | DSM-5 Advisors and Other Contributors 909
Stephane Jacobus, Ph.D.
Barry Sarvet, M.D.
Peter Thunfors, Ph.D.
Bruce Waslick, M.D.
Vicki Weld, L.I.C.S.W.
Sara Wiener, L.I.C.S.W.
Shadi Zaghloul, M.D.
Referring Clinicians
Sarah Detenber, L.I.C.S.W.
Gordon Garrison, L.I.C.S.W.
Jacqueline Humpreys, L.I.C.S.W.
Noreen McGirr, L.I.C.S.W.Sarah Marcotte, L.C.S.W.
Patricia Rogowski, R.N., C.N.S.
Research Coordinators
Julie Kingsbury, C.C.R.P., Lead Research
Coordinator
Brenda Martin, B.A.
Volunteer Research Assistant/
Intern
Liza Detenber
New York State Psychiatric Institute, New York, N.Y., Weill Cornell
Medical College, Payne Whitney and Westchester Divisions, New York
and White Plains, N.Y., and North Shore Child and Family Guidance
Center, Roslyn Heights, N.Y. (Joint Study Site)
Investigator
Prudence W. Fisher, Ph.D., Principal
Investigator
Research Coordinators
Julia K. Carmody, B.A., Lead Research
Coordinator
Zvi R. Shapiro, B.A., Lead Research
CoordinatorVolunteers
Preeya Desai
Samantha Keller
Jeremy Litfin, M.A.
Sarah L. Pearlstein, B.A.
Cedilla Sacher
New York State Psychiatric Institute
Referring and Interviewing Clinicians
Michele Cohen, L.C.S.W.
Eduvigis Cruz-Arrieta, Ph.D. | dsm5.pdf |
7d2f8f2a368f-1 | Eduvigis Cruz-Arrieta, Ph.D.
Miriam Ehrensaft, Ph.D.
Laurence Greenhill, M.D.
Schuyler Henderson, M.D., M.P.H.
Sharlene Jackson, Ph.D.
Lindsay Moskowitz, M.D.
Sweene C. Oscar, Ph.D.
Xenia Protopopescu, M.D.
James Rodriguez, Ph.D.
Gregory Tau, M.D.
Melissa Tebbs, L.C.S.W.
Carolina Velez-Grau, L.C.S.W.
Khadijah Booth Watkins, M.D.
Referring Clinicians
George Alvarado, M.D.
Alison Baker, M.D.
Elena Baron, Psy.D.
Lincoln Bickford, M.D., Ph.D.
Zachary Blumkin, Psy.D.
Colleen Cullen, L.C.S.W.
Chyristianne DeAlmeida, Ph.D.
Matthew Ehrlich, M.D.Eve Friedl, M.D.
Clare Gaskins, Ph.D.
Alice Greenfield, L.C.S.W.
Liora Hoffman, M.D.
Kathleen Jung, M.D.
Karimi Mailutha, M.D., M.P.H.
Valentina Nikulina, Ph.D.
Tal Reis, Ph.D.
Moira Rynn, M.D.
Jasmine Sawhney, M.D.
Sarajbit Singh, M.D.
Katherine Stratigos, M.D.
Oliver Stroeh, M.D.
Russell Tobe, M.D.
Meghan Tomb, Ph.D.
Michelle Tricamo, M.D.
Research Coordinators
Angel A. Caraballo, M.D. | dsm5.pdf |
7d2f8f2a368f-2 | Research Coordinators
Angel A. Caraballo, M.D.
Erica M. Chin, Ph.D.
Daniel T. Chrzanowski, M.D.
Tess Dougherty, B.A.
Stephanie Hundt, M.A.
Moira A. Rynn, M.D.
Deborah Stedge, R.N. | dsm5.pdf |
4ad90be2bba4-0 | 910 DSM-5 Advisors and Other Contributors
Weill Cornell Medical College, Payne Whitney and Westchester Divisions
Referring and Interviewing Clinicians
Archana Basu, Ph.D.
Shannon M. Bennett, M.D.
Maria De Pena-Nowak, M.D.
Jill Feldman, L.M.S.W.
Dennis Gee, M.D.
Jo R. Hariton, Ph.D.
Lakshmi P. Reddy, M.D.
Margaret Yoon, M.D.
Referring Clinicians
Margo Benjamin, M.D.
Vanessa Bobb, M.D.
Elizabeth Bochtler, M.D.
Katie Cave, L.C.S.W.
Maalobeeka Gangopadhyay, M.D.Jodi Gold, M.D.
Tejal Kaur, M.D.
Aaron Krasner, M.D.
Amy Miranda, L.C.S.W.
Cynthia Pfeffer, M.D.
James Rebeta, Ph.D.
Sharon Skariah, M.D.
Jeremy Stone, Ph.D.
Dirk Winter, M.D.
Research Coordinators
Alex Eve Keller, B.S., Lead Research Coordinator
Nomi Bodner (volunteer)
Barbara L. Flye, Ph.D.
Jamie S. Neiman (volunteer)
Rebecca L. Rendleman, M.D.
North Shore Child and Family Guidance Center
Referring and Interviewing Clinicians
Casye Brachfeld-Launer, L.C.S.W.
Susan Klein Cohen, Ph.D.
Amy Gelb, L.C.S.W.-R.
Jodi Glasser, L.C.S.W.
Elizabeth Goulding-Tag, L.C.S.W.
Deborah B. Kassimir, L.C.S.W. | dsm5.pdf |
4ad90be2bba4-1 | Deborah B. Kassimir, L.C.S.W.
Margo Posillico Messina, L.C.S.W.
Andréa Moullin-Heddle, L.M.S.W.
Lisa Pineda, L.C.S.W.
Elissa Smilowitz, L.C.S.W.
Referring Clinicians
Regina Barros-Rivera, L.C.S.W.-R. Assistant
Executive Director
Maria Christiansen, B.S.
Amy Davies-Hollander, L.M.S.W.
Eartha Hackett, M.S.Ed., M.Sc., B.Sc.Bruce Kaufstein, L.C.S.W.-R, Director of
Clinical Services
Kathy Knaust, L.C.S.W.
John Levinson, L.C.S.W.-R, B.C.D.
Andrew Maleckoff, L.C.S.W., Executive
Director/CEO
Sarah Rosen, L.C.S.W.-R, A.C.S.W.
Abigail Rothenberg, L.M.S.W.
Christine Scotten, A.C.S.W.
Michelle Spatano, L.C.S.W.-R.
Diane Straneri, M.S., R.N., C.S.
Rosara Torrisi, L.M.S.W.
Rob Vichnis, L.C.S.W.
Research Coordinators
Toni Kolb-Papetti, L.C.S.W.
Sheena M. Dauro (volunteer)
DSM-5 Field Trials Pilot Study,
Johns Hopkins Medical Institution, Baltimore, Maryland
Adult Sample
Community Psychiatry Outpatient Pr ogram, Department of Psychiatry
and Behavioral Sciences Main Campus
Investigators
Bernadette Cullen, M.B., B.Ch., B.A.O.,
Principal Investigator
Holly C. Wilcox, Ph.D., Principal Investigator | dsm5.pdf |
4ad90be2bba4-2 | Principal Investigator
Holly C. Wilcox, Ph.D., Principal Investigator
Referring and Interviewing
Clinicians
Bernadette Cullen, M.B., B.Ch., B.A.O.
Shane Grant, L.C.S.W.-C.
Charee Green, L.C.P.C.Emily Lorensen, L.C.S.W.-C.
Kathleen Malloy, L.C.P.C.
Gary Pilarchik, L.C.S.W.-C
Holly Slater, L.C.P.C.
Stanislav Spivak, M.D.
Tarcia Spencer Turner, L.C.P.C.
Nicholas Seldes Windt, L.C.S.W.-C.
Research Coordinators
Mellisha McKitty, B.A.
Alison Newcomer, M.H.S. | dsm5.pdf |
7cf0e7aa1d2b-0 | DSM-5 Advisors and Other Contributors 911
Pediatric Sample
Child and Adolescent Outpatient Progr am, Department of Psychiatry and
Behavioral Sciences Bayview Medical Center
Investigators
Joan P. Gerring, M.D., Principal Investigator
Leslie Miller, M.D., Principal Investigator
Holly C. Wilcox, Ph.D., Co-investigator
Referring and Interviewing
Clinicians
Shannon Barnett, M.D.
Gwen Condon, L.C.P.C.
Brijan Fellows, L.C.S.W.-C.
Heather Garner, L.C.S.W.-C.
Joan P. Gerring, M.D.Anna Gonzaga, M.D.
Debra Jenkins, L.C.S.W.-C.
Paige N. Johnston, L.C.P.C.
Brenda Memel, D.N.P., R.N.
Leslie Miller, M.D.
Ryan Moore, L.C.S.W.-C.
Shauna Reinblatt, M.D.
Monique Vardi, L.C.P.C.
Research Coordinators
Mellisha McKitty, B.A.
Alison Newcomer, M.H.S.
DSM-5 Field Trials in Routin e Clinical Practice Settings:
Collaborating Investigators
Archil Abashidze, M.D.
Francis R. Abueg, Ph.D.
Jennifer Louise Accuardi, M.S.
Balkozar S. Adam, M.D.
Miriam E. Adams, Sc.D., M.S.W., L.I.C.S.W.
Suzanna C. Adams, M.A.
Lawrence Adler, M.D.
Rownak Afroz, M.D.
Khalid I. Afzal, M.D.
Joseph Alimasuya, M.D. | dsm5.pdf |
7cf0e7aa1d2b-1 | Joseph Alimasuya, M.D.
Emily Allen, M.S.
Katherine A. Alle n, L.M.F.T., M.A.
William D. Allen, M.S.
Jafar AlMashat, M.D.
Anthony T. Al onzo, D.M.F.T.
Guillermo Alvarez, B.A., M.A.
Angela Amoia-Lutz, L.M.F.T.
Krista A. Anderson, M.A., L.M.F.T.
Lisa R. Anderson, M.Ed., L.C.P.C.
Pamela M. Anderson, L.M.F.T.
Shannon N. Anderson, M.A., L.P.C., N.C.C.
Eric S. Andrews, M.A.
Vicki Arbuckle, M.S., Nursing(N.P.)
Namita K. Arora, M.D.
Darryl Arrington, M.A.
Bearlyn Y. Ash, M.S.
Wylie J. Bagley, Ph.D.
Kumar D. Bahl, M.D.
Deborah C. Bailey, M.A., M.S., Ph.D.
Carolyn Baird, D.N.P., M.B.A., R.N.-B.C.,
C.A.R.N.-A.P., I.C.C.D.P.D.
Joelle Bangsund M.S.W.
Maria Baratta, M.S.W., Ph.D.
Stan Barnard, M.S.W.
Deborah Barnes, M.S.Margaret L. Barnes, Ph.D.
David Barnum, Ph.D.
Raymond M. Baum, M.D.
Edward Wescott Beal, M.D.
Michelle Beaudoin, M.A.
Ernest E. Beckham, Ph.D.
Lori L. Beckwith, M.Ed | dsm5.pdf |
7cf0e7aa1d2b-2 | Ernest E. Beckham, Ph.D.
Lori L. Beckwith, M.Ed
Emmet Bellville, M.A.
Randall E. Bennett, M.A.
Lynn Benson, Ph.D.
Robert Scott Benson, M.D.
Linda Benton, M.S.W.
Ditza D. Berger, Ph.D.
Louise I. Bertman, Ph.D.
Robin Bieber, M.S., L.M.F.T.
Diana M. Bigham, M.A.
David R. Blackburn, Ph.D.
Kelley Blackwell, L.M.F.T.
Lancia Blatchley, B.A., L.M.F.T.
Stacey L. Block, L.M.S.W., A.C.S.W.
Karen J. Bloodworth, M.S., N.C.C., L.P.C.
Lester Bloomenstiel, M.S.
Christine M. Blue, D.O.
Marina Bluvshtein, Ph.D.
Callie Gray Bobbitt, M.S.W., L.C.S.W.
Moses L. Boone, Jr., L.M.S.W., B.C.D.
Steffanie Boudreau-T homas, M.A.-L.P.C.
Jay L. Boulter, M.A.
Aaron Daniel Bourne, M.A.
Helen F. Bowden, Ph.D.
Aryn Bowley-Safranek, B.S., M.S.
Elizabeth Boyajian, Ph.D.
Beth K. Boyarsky, M.D.
Gail M. Boyd, Ph.D.
Jeffrey M. Brandler, Ed.S., C.A.S., S.A.P. | dsm5.pdf |
51e05e44f48b-0 | 912 DSM-5 Advisors and Other Contributors
Sandra L. Branton, Ed.D.
Karen J. Brocco-Kish, M.D.
Kristin Brooks, P.M.H.N.P.
Ann Marie Brown, M.S.W.
Philip Brown, M.S.W.
Kellie Buckner, Ed.S.
Richard Bunt, M.D.
Neil F. Buono, D.Min.
Janice Bureau, M.S.W., L.C.S.W.
Kimlee Butterfield, M.S.W.
Claudia Byrne, Ph.D.
Quinn Callicott, M.S.W., L.C.S.W.
Alvaro Camacho, M.D., M.P.H.
Sandra Cambra, Ph.D.
Heather Campbell, M.A.
Nancy Campbell, Ph.D., M.S.W.
Karen Ranee Canada, L.M.F.T.
Joseph P. Cannavo, M.D.
Catherine F. Caporale, Ph.D.
Frederick Capps, Ph.D., M.S.
Rebecca J. Carney, M.B.A., M.A., L.M.H.C.
Kelly J. Carroll, M.S.W.
Richard W. Carroll, Ph.D., L.P.C., A.C.S.
Sherry Casper, Ph.D.
Joseph A. Catania, L.I.S.W.S., L.C.D.C. III
Manisha P. Cavendish, Ph.D.
Kenneth M. Certa, M.D.
Shambhavi Chandraiah, M.D.
Calvin Chatlos, M.D.
Daniel C. Chen, M.D.
Darlene Cheryl, M.S.W.
Matthew R. Chirman, M.S.
Carole A. Chisholm, M.S.W. | dsm5.pdf |
51e05e44f48b-1 | Carole A. Chisholm, M.S.W.
Shobha A. Chottera, M.D.
Joseph Logue Christenson, M.D.
Pamela Christy, Psy.D.
Sharon M. Freeman Clevenger, Ph.D.,
P.M.H.C.N.S.-B.C.
Mary Ann Cohen, M.D.
Mitchell J. Cohen, M.D.
Diego L. Coira, M.D.
Melinda A. Lawless Coker, Psy.D.
Carol Cole, M.S.W., L.C.S.W.
Caron Collins, M.A., L.M.F.T.
Wanda Collins, M.S.N.
Linda Cook Cason, M.A.
Ayanna Cooke-Chen, M.D., Ph.D.
Heidi B. Cooperstein, D.O.
Ileana Corbelle, M.S.W.
Kimberly Corbett, Psy.D.
Angelina Cordova, M.A.Ed.
Jennifer Carol Cox, L.P.C.
Sheree Cox, M.A., R.N., N.C.C., D.C.C.,
L.M.H.C.
William Frederick Cox, M.D.
Sally M. Cox, M.S.Ed.
Debbie Herman Crane, M.S.W.
Arthur Ray Crawford, III, Ph.D.Roula Creighton, M.D.
John R. Crossfield, L.M.H.C.
Sue Cutbirth, R.N., M.S.N, C.S., P.M.H.N.P.
Marco Antonio Cuyar, M.S.
Rebecca Susan Daily, M.D.
Lori S. Danenberg, Ph.D.
Chan Dang-Vu, M.D.
Mary Hynes Danielak, Psy.D.
Cynthia A. Darby, M.Ed., Ed.S. | dsm5.pdf |
51e05e44f48b-2 | Cynthia A. Darby, M.Ed., Ed.S.
Douglas Darnall, Ph.D.
Christopher Davidson, M.D.
Doreen Davis, Ph.D., L.C.S.W.
Sandra Davis, Ph.D., L.M.H.C., N.C.C.
Walter Pitts Davis, M.Th.
Christian J. Dean, Ph.D.
Kent Dean, Ph.D.
Elizabeth Dear, M.A.
Shelby DeBause, M.A.
Rebecca B. DeLaney, M.S.S.W., L.C.S.W., B.C.D.
John R. Delatorre, M.A.
Frank DeLaurentis, M.D.
Eric Denner, M.A., M.B.A.
Mary Dennihan, L.M.F.T.
Kenny Dennis, M.A.
Pamela L. Detrick, Ph.D., M.S., F.N.P.-B.C.,
P.M.H.N.P.-B.C., R.N.-B.C., C.A.P.,
G.C.A.C.
Robert Detrinis, M.D.
Daniel A. Deutschman, M.D.
Tania Diaz, Psy.D.
Sharon Dobbs, M.S.W., L.C.S.W.
David Doreau, M.Ed.
Gayle L. Dosher, M.A.
D'Ann Downey, Ph.D., M.S.W.
Beth Doyle, M.A.
Amy J. Driskill, M.S., L.C.M.F.T.
James Drury, M.D.
Brenda-Lee Duarte, M.Ed.
Shane E. Dulemba, M.S.N.
Nancy R. G. Dunbar, M.D.
Cathy Duncan, M.A. | dsm5.pdf |
51e05e44f48b-3 | Cathy Duncan, M.A.
Rebecca S. Dunn, M.S.N., A.R.N.P.
Debbie Earnshaw, M.A.
Shawna Eddy-Kissell, M.A.
Momen El Nesr, M.D.
Jeffrey Bruce Elliott, Psy.D.
Leslie Ellis, Ph.D.
Donna M. Emfield, L.C.P.C.
Gretchen S. Enright, M.D.
John C. Espy, Ph.D.
Renuka Evani, M.B.B.S., M.D.
Heather Evans, M.S.Ed, L.P.C.N.C.C.
Cesar A. Fabiani, M.D.
Fahim Fahim, M.D.
Samuel Fam, M.D.
Edward H. Fankhanel, Ph.D., Ed.D.
Tamara Farmer, M.S.N, A.R.N.P.
Farida Farzana, M.D. | dsm5.pdf |
ce89a93a9253-0 | DSM-5 Advisors and Other Contributors 913
Philip Fast, M.S.
Patricia Feltrup-Exum, M.A.M.F.T.
Hector J. Fernandez-Barillas, Ph.D.
Julie Ferry, M.S.W., L.I.C.S.W.
Jane Fink, Ph.D., M.S.S.A.
Kathy Finkle, L.P.C.M.H.
Steven Finlay, Ph.D.
Rik Fire, M.S.W., L.C.S.W.
Ann Flood, Ph.D.
Jeanine Lee Foreman, M.S.
Thyra Fossum, Ph.D.
Karen S. Franklin, L.I.C.S.W.
Sherre K. Franklin, M.A.
Helen R. Frey, M.A., E.D.
Michael L. Freytag, B.S., M.A.
Beth Gagnon, M.S.W.
Patrice L.R. Gallagher, Ph.D.
Angela J. Gallien, M.A.
Robert Gallo, M.S.W.
Mario Galvarino, M.D.
Vladimir I. Gasca, M.D.
Joshua Gates, Ph.D.
Anthony Gaudioso, Ph.D.
Michelle S. Gauthier, A.P.R.N., M.S.N,
P.M.H.N.P.-B.C.
Rachel E. Gearhart, L.C.S.W.
Stephen D. Gelfond, M.D.
Nancy S. Gerow, M.S.
Michael J. Gerson, Ph.D.
Susan M. A. Geyer, L.M.S.W.
Lorrie Gfeller-Strouts, Ph.D.
Shubu Ghosh, M.D.
Richard Dorsey Gillespie, M.Div.
Stuart A. Gitlin, M.S.S.A. | dsm5.pdf |
ce89a93a9253-1 | Stuart A. Gitlin, M.S.S.A.
Jeannette E. Given, Ph.D.
Frances Gizzi, L.C.S.W.
Stephen I. Glicksman, Ph.D.
Martha Glisky, Ph.D.
Sonia Godbole, M.D.
Howard M. Gold fischer, Psy.D.
Mary Jane Gonzalez-Huss, Ph.D.
Michael I. Good, M.D.
Dawn Goodman-Martin, M.A.-L.M.H.C.
Robert Gorkin, Ph.D., M.D.
Jeff Gorski, M.S.W.
Linda O. Graf, M.Ed., L.C.P.C.
Ona Graham, Psy.D.
Aubrie M. Graves, L.M.S.W., C.A.S.A.C.
Howard S. Green, M.D.
Karen Torry Green, M.S.W.
Gary Greenberg, Ph.D.
Marjorie Greenhut, M.A.
James L. Greenstone, Ed.D., J.D.
Raymond A. Griffin, Ph.D.
Joseph Grillo, Ph.D.
Janeane M. Grisez, A.A., B.A.
Lawrence S. Gross, M.D.
Robert J. Gross, M.D.Sally J. Grosscup, Ph.D.
Philip A. Grossi, M.D.
Gabrielle Guedet, Ph.D.
Nicholas Guenzel, B.A., B.S., M.S.N.
Mary G. Hales, M.A.
Tara C. Haley, M.S., L.M.F.T.
John D. Hall, M.D.
Amy Hammer, M.S.W.
Michael S. Hanau, M.D.
Linda K.W. Hansen, M.A., L.P. | dsm5.pdf |
ce89a93a9253-2 | Linda K.W. Hansen, M.A., L.P.
Genevieve R. Hansler, M.S.W.
Mary T. Harring ton, L.C.S.W.
Lois Hartman, Ph.D.
Steven Lee Hartsock, Ph.D., M.S.W.
Victoria Ann Harwood, M.S.W., L.C.S.W.
Rossi A. Hassad, Ph.D., M.P.H.
Erin V. Hatcher, M.S.N.
Richard L. Hauger, M.D.
Kimberly M. Haverly, M.A.
Gale Eisner Heater, M.S., M.F.T.
Katlin Hecox, M.A.
Brenda Heideman, M.S.W.
Melinda Heinen, M.Sc.
Marie-Therese Heitkamp, M.S.
Melissa B. Held, M.A.
Jessica Hellings, M.D.
Bonnie Helmick-O'Brien, M.A., L.M.F.T.
MaLinda T. Henderson, M.S.N, F.P.M.H.N.P.
Gwenn Herman, M.S.W.
Martha W. Hernandez, M.S.N, A.P.R.N.,
P.M.H.C.N.S.
Robin L. Hewitt, M.S.
Kenneth Hoffman, Ph.D.
Patricia E. Hogan, D.O.
Peggy Holcomb, Ph.D.
Garland H. Holloman, Jr., M.D.
Kimberly Huegel, M.S.W., L.C.S.W.
Jason Hughes, L.P.C.-S., N.C.C.
Jennifer C. Hughes, Ph.D., M.S.W., L.I.S.W.-S.
Michelle K. Humke, M.A.
Judith G. Hunt, L.M.F.T. | dsm5.pdf |
ce89a93a9253-3 | Judith G. Hunt, L.M.F.T.
Tasneem Hussainee, M.D.
Sharlene J. Hutchinson, M.S.N.
Muhammad Ikram, M.D.
Sunday Ilechukwu, M.D., D.Psy. Cli.
Douglas H. Ingram, M.D.
Marilynn Irvine, Ph.D.
Marjorie Isaacs, Psy.D.
Raymond Isackila, Ed.S., P.C.C.-S., L.I.C.D.C.
Mohammed A. Issa, M.D.
John L. Jankord, M.A.
Barbara P. Jannah, L.C.S.W.
C. Stuart Johnson, M.S.
Dawn M. Johnson, M.A.
Deanna V. Johnson, M.S., A.P.R.N., B.C.
Eric C. Johnson, M.F.T.
Joy Johnson, Ph.D., L.C.S.W.
Willard Johnson, Ph.D. | dsm5.pdf |
0c456b87884d-0 | 914 DSM-5 Advisors and Other Contributors
Xenia Johnson-Bhembe, M.D.
Vann S. Joines, Ph.D.
Margaret Jones, Psy.D.
Patricia Jorgenson, M.S.W.
Steven M. Joseph, M.D.
Taylere Joseph, M.A.
Jeanette M. Joyner-Craddock, M.S.S.W.
Melissa Kachapis, M.A.
Charles T. Kaelber, M.D.
Aimee C. Kaempf, M.D.
Peter Andrew Kahn, M.D.
Robert P. Kahn-Rose, M.D.
Maher Karam-Hage, M.D.
Todd H. Kasdan, M .D.
Karen Kaufman, M.S., L.M.F.T.
Rhesa Kaulia, M.A., M.F.T.
Debbie Lynn Kelly, M.S.N, P.M.H.N.P.-B.C.
W. Stephen Kelly, Ph.D.
Selena Kennedy, M.A.
Judith A. Kenney, M.S., L.P.C.
Mark Patrick Kerekes, M.D.
Alyse Kerr, M.S., N.C.C., N.A.D.D.-C.C., L.P.C.
Karen L. Kerschmann, L.C.S.W.
Marcia Kesner, M.S.
Ashan Khan, Ph.D.
Shaukat Khan, M.D.
Audrey Khatchikian, Ph.D.
Laurie B. Kimmel, M.S.W.
Jason H. King, Ph.D.
Nancy Leigh King, M.S.W., L.C.S.W., L.C.A.S.
Kyle Kinne, M.S.C
Cassandra M. Klyman, M.D.
David R. Knapp, L.C.S.W. | dsm5.pdf |
0c456b87884d-1 | David R. Knapp, L.C.S.W.
Margaret Knerr, M.S.
Michael R. Knox, Ph.D.
Carolyn Koblin, M.S.
Valerie Kolbert, M.S., A.R.N.P.-B.C.
Heather Koontz, M.S.W.
Faye Koop, Ph.D., L.C.M.F.T.
Fern M. Kopakin, M.S.W., L.C.S.W.
Joel Kotin, M.D.
Sharlene K. Kraemer, M.S.E.
Marjorie Vego Krausz, M.A., Ed.D.
Nancy J. Krell, M.S.W.
Mindy E. Kronenberg, Ph.D.
Dwayne Kruse, M.S., M.F.T.
Ajay S. Kuchibhatla, M.D.
Shubha N. Kumar, M.D.
Helen H. Kyomen, M.D., M.S.
Rebecca M. Lachut, M.Ed., Ed.S.
Alexis Lake, M.S.S.
Ramaswamy Lakshmanan, M.D.
Brigitta Lalone, L.C.S.W.-R
John W. Lancaster, Ph.D.
Patience R. Land, L.I.C.S.W., M.S.W., M.P.A.
Amber Lange, M.A., Ph.D.
Jeff K. Larsen, M.A.
Nathan E. Lavid, M.D.Michelle Leader, Ph.D.
Stephen E. Lee, M.D.
Cathryn L. Leff, Ph.D., L.M.F.T.
Rachael Kollar Leombruno, L.M.F.T.
Arlene I. Lev, M.S.W., L.C.S.W.-R | dsm5.pdf |
Subsets and Splits